






























Department of chemistry, Graduate school of science and 













論 文 名 
Studies of genome maintenance mechanisms using gene-editing technology 
 






 主 査 
 
 委 員 
 







  平成  年  月  日 
  首都大学東京大学院理工学研究科教授会 




DISSERTATION FOR A DEGREE OF 
DOCTOR OF PHILOSOPHY IN SCIENCE 

















  Examiner 
 
 
QUALIFIED BY THE GRADUATE SCHOOL  
OF SCIENCE AND ENGINEERING 

















Chapter 1: Analysis of the role of ALC1 in Base Excision repair 
1-1 Introduction  
1-1-1 The Biological roles of Poly ADP Ribose Polymerase          21 
1-1-2 ALC1 and Base excision repair 22 
1-1-3 PARP works together with Tyrosyl DNA Phosphodiesterase 1 24 
1-2 Materials 27 
1-3 Experimental methods 29 
1-4 Results  
1-4-1 Analysis of sensitivity profile of ALC1 mutant 33 
1-4-2 The epistatic analysis between ALC1 and PARP 34 
1-4-3 The role of ALC1 in Base Excision Repair 35 
1-4-4 ALC1 promote BER independently of XRCC1 38 
1-4-5 ALC1 promotes BER by inducing chromatin remodeling through histone eviction 42 
1-4-6 The role of ALC1 to tolerate CPT-induced DNA damage        44 
1-4-7 ALC1 promotes chromatin relaxation around DNA replication to tolerate CPT-induced 
DNA damage               47 
1-4-8 ALC1 does not suppress toxic NHEJ above CPT         49 
1-4-9 ALC1 prevents replication-fork collapse by slowing fork progression                           50 
1-5 Discussion  
1-5-1 ALC1 works with PARP as a chromatin remodeler in the base excision repair but 
independent of XRCC1 53 
1-5-2 ALC1 prevents replication-fork collapse by slowing fork progression 54 





Chapter 2: Warsaw breakage syndrome DDX11 helicase acts jointly with RAD17 in 
the repair of bulky lesions and replication through abasic sites  
2-1 Introduction  
2-1-1 Warsaw Breakage Syndrome and DDX11 56 
2-1-2 Fanconi anemia 57 
2-1-3 DNA damage during DNA replication                                 58 
2-2 Materials and methods 60 
2-3 Results  
2-3-1 DDX11 Helicase Facilitates Repair and Averts Genomic Instability Induced by 
Interstrand cross links 63 
2-3-2 DDX11 Functions as Backup to the FA Pathway in ICL Repair 64 
2-3-3 DDX11 Facilitates DNA Repair by Homologous Recombination 65 
2-3-4 DDX11 Acts Jointly with 9-1-1 to Facilitate Post-replicative DNA Repair 70 
2-3-5 DDX11 Facilitates Ig Hypermutation and Gene Conversion 76 
2-4 Discussion  
2-4-1 DDX11 works as a backup for Fanconi anemia pathway in the repair of DNA inter-
strand cross link 78 
2-4-2 DDX11 facilitate DNA damage tolerance dependently on 9-1-1 check point clamp 78 
 
Chapter 3: Molecular Mechanism-Based High Throughput Screening to Identify the 
Chemicals Which Cause DNA Double-Strand Break Through Estrogen Receptor 
Activation 
3-1 Introduction  
3-1-1 Translational Science 81 
3-1-2 Nuclear hormone receptor and cancer therapy 81 
3-1-3 Female organ cancer and Estrogen / Progestrone receptor 82 
3-1-4 Female organ cancer and BRCA1                      83 
3-1-5 High content / High throughput screening          85 
3-2 Materials and methods 86 
3-3 Results  
3-3-1 Development of the assay system to identify DNA double strand break inducer 91 
3-3-2 Identification of phospho-H2AX inducer using high content imaging analysis 94 
 6 
3-3-3 12 compounds induce phospho-H2AX depending on Estrogen receptor  98 
3-4 Discussion 100 
General discussion 101 












ALC Amplified in Liver Cancer 1 
AP site apurinic/apyrimidinic site 
ATP Adenosine triphosphate 
BER Base excision repair 
DDR DNA damage repair 
DDT DNA damage tolerance 
DDX11 DEAD/H-Box Helicase 11 
DNA Deoxyribonucleic acid 
DSB DNA double strand break 
ER Estrogen receptor 
FA Fanconi Anemia 
FANC proteins Fanconi Anemia complementation proteins 
H2O2 Hydrogen peroxide 
HR Homologous Recombination 
ICL Interstrand cross link 
MMS Methyl methanesulfonate 
mRNA messenger RNA 
NCATS National center for advancing translational science 
NHEJ Non Homologous End Joining 
NIH National institute of Health 
PAR Poly ADP ribose 
PARP Poly (ADP-ribose) polymerase 
PCNA Proliferating cell nuclear antigen 
Pol polymerase 
PTM Post-translational modification 
qHTS quantitative high throughput screening 
ROS Reactive oxygen species 
RT Room temperature 
SSB Single Strand Break 
TLS Translesion DNA synthesis 
Top1 Topoisomerase I 
Top1-cc Topoisomerase I DNA Covalent Complexes 
TS Template Switch 
UV Ultra Violet 






              理工学研究科 分子物質化学専攻  
                                                                                               大岡 正人                   
  




 A genome is a complete set of an organism’s genetic information written in chromosomal DNA. 
Genome information includes all living species’ genes. Our body is built and maintained according to the 
genome information. The genome maintenance system is strictly controlled by a variably of enzymes. This 
highly organized regulation can be destroyed even by a single nucleotide mutation in our genome, leading 
to cancer or other severe diseases. Advancements in genome sequencing technology has allowed us to 
clarify the relationships between diseases and genes. We believe that cancer is caused by genome 
mutations. The genome DNA is not only damaged by external factors (eg. UV and ionizing radiation), but 
also internal factors caused by our own metabolism.  Cells are equipped with several DNA repair pathways 
to prevent our genome from such DNA damage. Cells use proper repair enzymes and mechanisms 
according to the type of DNA damage and the cell cycle phase. However, the repair mechanism is not 
perfect, and cells occasionally fail to repair DNA damage properly. When cells fail to repair DNA damage, 
unrepaired damage causes mutations, translocation, or other genome instabilities. Although numerous 
researchers have studied DNA repair mechanisms, there are still many pieces missing. In this study, I 
analyze the role played by ALC1 chromatin remodeling enzyme in base excision repair (BER), DDX11 
helicase enzyme in DNA damage tolerance system, and identify several previously unknown synthetic 
relationships between genes in genome maintenance. In addition, I have created a high throughput drug 
screening system, based on DNA damage in cells, to potentially create a novel cancer chemotherapy 
through synthetic lethality using specific inhibitors for DNA repair enzymes. 
The most common DNA damage type is base damage DNA. To repair this damage, base excision 
repair (BER) is required. Generally, BER consists of three enzymatic-steps: (1) Removal of damaged bases 
by glycosylase-enzyme, leading the formation of abasic (AP) site. (2) Incision of the DNA backbone at 
the 5' end of AP site by AP endonuclease-enzyme, yielding single strand breaks (SSBs). (3) The repair of 
SSBs, which is the slowest enzymatic step in BER and SSBs, can be detected as a BER intermediates. In 
this process, Poly(ADP-ribose) polymerase (PARP) accumulates at SSBs which causes PARP to induce 
Poly ADP-ribosylation in PARP itself and chromatin proteins. XRCC1 recognizes this modification and 
recruits Polβ-enzyme and Lig3-enzyme to the damage site. Polβ-enzyme induces incision of 3’ end of AP 
site and removes the resultant 5’-deoxyribose. DNA polymerase(s) performs gap-filling DNA synthesis 
leaving a DNA nicked substrate for DNA ligation by Lig3-enzyme. Recently, ALC1, a chromatin 
remodeling-enzyme, was found to have Poly(ADP-ribose) interacting domain and catalyze PARP-
stimulated nucleosome sliding. However, the role played by ALC1 in genome maintenance system has not 
been elucidated. 
Warsaw breakage syndrome, a developmental disorder, is caused by mutations in DDX11 helicase 
enzyme. This disease shows cellular features of genome instability similar to Fanconi anemia (FA). The 
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common feature of FA cells is hypersensitivity to interstrand-crosslink (ICL). It is believed that the 
enzymes mutated in FA are implicated in ICL repair. ICL repair employs several distinct repair pathways 
such as excision repair, homologous recombination (HR) and translesion DNA synthesis (TLS), which are 
believed to be orchestrated by the FA enzymes. Generally, helicase enzyme catalyzes the separation of 
double-stranded DNA into single strands during DNA replication and DNA repair. However, the way 
DDX11 helicase contributes to ICL repair remains unclear. Moreover, the relationship between DDX11 
helicase and FA pathway has been largely unknown. 
 
  
1.  Analysis of the role played by ALC1 in DNA damage repair 
 I explored ALC1's role in DNA repair. Because ALC1 has Poly(ADP-ribose) interacting domain, 
I first focused on BER and a genetic relationship with PARP1. In viability assay, ALC1-/- mutant shows 
hypersensitivity to MMS and H2O2, which cause base damages. I identified the epistatic relationship 
between ALC1-/- and PARP1-/- in cellular resistance to MMS and H2O2. I performed alkaline-comet assay, 
which measures single strand break (SSB), an intermediate of BER. ALC1-/- cells showed slower repair-
kinetics of SSB than wild-type cells. This data suggests that ALC1 promotes BER after SSB formation. I 
found that ALC1 contributes to the PARP-dependent promotion of BER without affecting the recruitment 
of XRCC1 and Polβ to DNA lesions. I thus conclude that ALC1 plays a key role in BER repair coupled 
with PARP but independent of both of the key repair proteins in BER, XRCC1 and Polβ. 
To identify other role(s) of ALC1 in DNA repair, I treated ALC1-/- mutant with various DNA 
damaging agents and measured the sensitivity. Unexpectedly, ALC1-/- mutant showed higher sensitivity to 
Camptothecin (CPT) than wild-type did. CPT induces single-strand breaks covalently attaching to Top1 
with its 3’ terminus (TOP1-DNA cleavage complex (TOP1cc)). To suppress DSB formation, replication 
fork slows via PARP-mediated fork reversal. Strikingly, ALC1-/- cells showed impaired fork slowing. 
Moreover, PARP1-/- and PARP1-/-/ ALC1-/- cells show similar sensitivity to CPT. This epistatic relationship 
suggests that ALC1 plays roles in PARP-mediated fork-reversal. 
  
2. Analysis of the role played by DDX11 in DNA damage repair 
         I sought the role of DDX11 in DNA repair and DNA replication and the functional relationship 
between DDX11 and FA proteins. Both DDX11-/- and FANCC-/- mutants showed less capability to repair 
DNA interstrand crosslinks (ICL) than wild type did. FA deficient mutant showed much higher sensitivity 
to ICL inducer than DDX11-/- mutant. DDX11-/-/FANCC-/- mutant showed higher sensitivity to ICL inducer 
than each single mutant. I concluded DDX11 works as a critical back-up pathway for FA pathway to repair 
ICL. DDX11-/- mutant showed higher sensitivity to DNA replication stress. DNA replication stress is often 
bypassed by Trans lesion DNA synthesis (TLS) or HR dependent template-switch. To test if DDX11 has 
a role to tolerate DNA replication stress, I measured the frequency of TLS and HR dependent gene-
conversion in Immunoglobulin variable (IgV) gene during IgV diversification. This assay allows us to 
measure the frequency of both TLS and HR. DDX11-/- mutant showed less frequency of both TLS and HR 
at IgV locus, suggesting the pivotal role of DDX11 to tolerate DNA replication stress. 
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3. Development of high throughput drug screening system using image analysis of DNA damages in 
cells 
         I identified synthetic effects of concurrent loss of DDX11 and FA factor on genome maintenance 
and cell proliferation. Thus, the rapid proliferation of FA cancer cells might be largely supported by the 
complementary working DDX11. Similarly, genes related to DNA damage repair pathways are generally 
mutated in cancer cells and thus the survival of the cancer cells is maintained by alternative and 
complementary DNA repair pathways. The inhibition of such complementary system results in cell growth 
defect or cell death.  To establish the novel cancer chemotherapy based on such genetic synthetic-
relationship, I wish to establish a high throughput drug screening system based on imaging analysis of 
DNA damages in cells. 
To find a better cell-based high-throughput assay system to quickly identify DNA double strand 
break (DSB) in cells, I optimized and validated an immunostaining assay using a quantitative high-
throughput and high-content imaging method. To validate this assay, MCF7 cells were plated in a 1536-
well plate. The MCF7 cells were treated with bleomycin, a known DNA damage inducer, which causes 
phosphorylation on H2AX in a concentration-dependent manner. Phospho-H2AX was used as a biomarker 
for DNA damage. In the screening, the number of foci per cell was used for quantitative image analysis of 
phospho-H2AX induction using Operetta High Content Imaging System. The immunostaining assay was 
validated in 1536-well formats using Bleomycin with average signal-to-background (S/B) ratio, 
coefficient of variation (CV) value, and Z’ factor of 26.7, 10.1%, and 0.62, respectively. 
I screened 907 compounds from Tox21-10K chemical library at the National Center for 
Advancing Translational Science/ National Institutes of Health (NCATS/NIH). These compounds were 
directly or indirectly related to DSB from previous screenings done at NCATS/NIH. The average CV value, 
S/B ratio, and Z’ factor from the primary screen of 21 assay plates were 14.85%, 5.53, and 0.32, 
respectively. The compounds, with efficacy of >3SD from the negative control (DMSO), were considered 
active and potential phospho-H2AX inducers. A total of 128 potential inducers were identified from the 
primary screening. 
In this study, I achieved three things. First, that ALC1 works as a chromatin remodeler together 
with PARP in BER. ALC1 also works in the repair of Camptothecin-induced DNA damage. Second, that 
DDX11 works as a backup of Fanconi anemia pathway in the repair of DNA interstrand crosslink. 
Furthermore, I identified DDX11’s role in DNA replication and the relationship between DDX11 and other 
proteins which work to tolerate DNA replication stress. Finally, I optimized a high throughput imaging 




Genome and Cancer 
 
 A genome is a complete set of an organism’s genetic information including all of genes. Our 
body is built according to the genome information. Human’s genetic information consists of 
more than 3 billion ATCG letters written in DNA molecules. The gigantic molecules form a 
compactly folded structure called chromatin to be fit into the nuclei. Chromatin is a complex 
of DNA and histones (Figure 1). DNA wraps around histones, forming a nucleosome. 
Nucleosomes condense into a more compact structure. The roles of chromatin are 1) compact 
the DNA, 2) regulating gene expression and DNA replication and 3) preventing DNA damage 
(Venkatesh and Workman, 2015). These functions are strictly controlled by many enzymes. 




Figure 1  
 
 Chromatin structure and the roles. 
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Improvement of genome sequencing technology allows us to clarify the relationships 
between disease and genes. We have an idea that cancer is a disease of the genome. The 
function of our body consists of numerous numbers of cells. Each cell has a role to maintain 
our life. The roles are strictly controlled by tens of thousands of enzymes. This highly 
organized regulation can be destroyed even by a single nucleotide mutation in our genome, 
leading to cancer or other severe diseases. Our genome is inherited from parents. If the 
parents have mutations in their genome, the same mutation can be found in the genome of 
the children according to the Mendelian inheritance. Another way of occurrence of mutation 
is a result of DNA damage. Our genome is continuously damaged by many factors, such as 
reactive oxygen species, environmental hormones, UV, etc (Carol Bernstein, Anil R. Prasad, 
Valentine Nfonsam and Harris Bernstein, 2012, the book” New Research Directions in DNA 
Repair”). There are several DNA repair pathways (Kelley and Fishel, 2016). Once our DNA 
is damaged, the DNA repair mechanism works to protect the genome. Proper repair enzymes 
and mechanisms are used depending on a type of DNA damage. However, the repair 
mechanism is not perfect. Cells occasionally fail to repair them properly. When cells make 
mistakes to repair DNA damages, it causes mutations, translocation or other genome 
instabilities (Ganem and Pellman, 2012). The most common DNA damage is DNA base 
damages by reactive oxygen species, which are produced endogenously (Carol Bernstein, 
Anil R. Prasad, Valentine Nfonsam and Harris Bernstein, 2012, the book” New Research 
Directions in DNA Repair”). Such DNA damages arise more than 10,000 times a day. This 
type of DNA damage is repaired by a repair mechanism referred to as base excision repair. 
 
 
Base Excision Repair and Single Strand Break Repair 
 
 Base excision repair (BER) is one of the DNA repair mechanisms (Figure 2) (Liu et al., 
2007). As the name suggests, it eliminates damaged bases by oxidation, alkylation, and 
hydrolysis. Since reactive oxygen species are a by-product of a metabolic reaction in cells, 
these damages are inevitable. Several enzymes are involved in the BER process. A typical 
BER is initiated by enzymatic removal of the damaged base, leading to the formation of 
apurinic/apyrimidinic (AP) sites, followed by incision of the DNA backbone at the AP sites, 
yielding single-strand breaks (SSBs) (Liu et al., 2007). Since SSB repair and BER share many 
repair factors, such as Poly (ADP-ribose) polymerase (PARP) 1 and 2, SSB repair is 
considered as a BER sub-pathway. PARP1 and PARP2 accumulate quickly at SSB sites, and 
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poly ADP-ribosylate themselves as well as chromatin proteins around the SSB site 
(Chaudhuri et al., 2012). Poly (ADP-ribose) facilitates the recruitment of x-ray-repair cross-
complementing group 1 (XRCC1). XRCC1 plays a key role in SSB repair by providing 
docking sites for critical effector molecules, polynucleotide kinase 3'-phosphatase (PNKP), 
DNA polymerase β (Polβ), and ligase 3. PNKP and Polβ restore hydroxyl and 
phosphorylation residues at the 3' and 5' ends, respectively, of the SSBs. Polβ incorporates a 
single nucleotide, a process called short-patch repair synthesis, for subsequent ligation of 
SSBs. Polβ, Polδ, and Polθ, on the other hand, undergo long-patch repair synthesis, involving 
2±12 nucleotide incorporation, by strand-displacement synthesis, generating a 5' flap. The 





Figure 2  
The scheme of Base excision repair. When base damage occurs (A), DNA glycosylase 
removes the DNA, leaving AP site (B). After the AP site is cleaved by AP endonuclease (C), 
a single-strand break (SSB) remains. PARP recognizes the SSB and Poly-ADP ribosylates 
histone proteins and PARP itself (D). In short patch pathway, XRCC1 binds to poly ADP 
ribose and works as a scaffold protein for other BER proteins such as Pol β. In the long 













flipped DNA. DNA ligase 3 completes the repair by ligating the DNA ends (H). 
 
 
DNA Double Strand Break Repair 
 
DNA double-strand break (DSB) is the most toxic type of DNA damage. DSB is the DNA 
damage which shows breaks at the same position in the duplex DNA. Unrepaired breaks can 
lead to cell death and improper repair can cause toxic genetic rearrangement. DSBs are 
repaired mainly by two repair pathways. One is non-homologous end joining (NHEJ) and the 
other is homologous recombination (HR) (Ceccaldi et al., 2016a). Many researchers tried to 
reveal the repair mechanisms. We have the detail, still not perfect, mechanism of the repairs. 
 
 NHEJ pathway is the commonest DSB repair pathway in human cells (Figure 3). NIHEJ is 
active throughout the cell cycle (Ceccaldi et al., 2016a). NHEJ is triggered by a binding of 
the Ku70-Ku80 heterodimer to DSB ends. Ku70-Ku80 complex works as a scaffold to recruit 
other NHEJ factors, including DNA-dependent protein kinase catalytic subunit (DNA-PKcs), 
DNA ligase4 (LIG4), X-ray repair cross-complementing protein 4 (XRCC4), etc. Once 
DNA-PKcs is recruited to the DSB site, it phosphorylates several NHEJ factor and itself. 
XRCC4-LIG4 complex ligates the broken DNA ends. Because NHEJ seals the two edges 
without applying homology, it can induce unscheduled insertion, deletion, or chromosome 
translocation. 
 
Figure 3  
The scheme of Non-Homologous End Joining. 
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 HR is the second most common DSB repair pathway in human cells (Figure 4). It is an error-
free pathway that uses a homologous sequence in the sister chromosome to copy the damaged 
sequence(Ceccaldi et al., 2016a). It is activated usually in S/G2 phase. In this pathway, when 
DSB occurs, CtIP and Mre11-Rad50-Nbs1(MRN) complex binds to DSB sites and resects 
the DNA end, resulting in 3’ overhang. After the resection, Rad51 forms nucleoprotein 
filaments around 3’ overhang to find a homologous sequence. Once the homologous 
sequence is found, the 3’ overhang strand invades into the homologous DNA, forming a D-





Figure 4  
 
The scheme of homologous recombination. 
 
 
 These two pathways are regulated by the balance between breast cancer type 1 susceptibility 
protein (BRCA1) and p53 binding protein 1(53BP1) (Fig5). While 53BP1 prevents DNA 
resection by keeping CtIP from accessing DNA ends and promotes NHEJ, BRCA1 promotes 
the removal of 53BP1 in S-phase and directs HR (Daley and Sung, 2014). In the absence of 
BRCA1, DSB end resection is not carried properly, leading to embryonic lethality. This 
lethality is suppressed by knockout of 53BP1 in mouse, suggesting BRCA1 plays an 
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important role in the removal of 53BP1 and regulation in the DSB repair pathway choice 





Figure 5 Model for DSB repair choice in G1 and S/G2 
(Left) In G1 cells, 53BP1 localizes at the break. Other NHEJ proteins RIF1 are recruited to 
the damaged DNA and block the resection. (Right) In S/G2 cells, BRCA1 and MRN form 




DNA Replication Stress 
 
 DNA polymerases synthesize DNA by inserting nucleotides, which are complementary to 
template strand. DNA replication frequently stalls at the DNA damage site. Stalled replication 
fork causes replication fork collapse. Cells have evolved DNA damage tolerance (DDT) 
mechanisms (Figure 6), including trans-lesion DNA synthesis (TLS), template switching 
(TS) to tolerate replication stress (Abe et al., 2018). DDT prevents replication fork collapse. 
These two mechanisms are regulated by ubiquitylation on proliferating cell nuclear antigen 
(PCNA) on the stalled replication fork by ubiquitin ligases (Arakawa et al., 2006). 
 TLS is initiated by a mono-ubiquitylation on PCNA. When PCNA is ubiquitylated, DNA 
replicative polymerases are replaced with TLS polymerases (TLS pols), which are 
specialized for TLS. TLS pols include polymerase ζ, η, κ, etc. DNA damages often distort 
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DNA or make DNA bulky. Since replicative DNA polymerases have a narrow nucleotide 
pocket for accurate insertion of a nucleotide, the distorted or bulky DNA cannot be 
accommodated in the pocket. On the other hand, TLS Pols have a broad nucleotide pocket. 
Therefore, they can synthesize DNA over damaged template with low fidelity (Vaisman and 
Woodgate, 2017).  
 TS is initiated by polyubiquitylation on PCNA. TS employs many HR-related proteins. 
Stalled newly synthesized DNA invades the sister chromatid and continues synthesizing by 
using sister chromatid as a template. Since the correct DNA sequence is used as a template 
in this process, TS is error-free. 
 In addition to TLS and TS, cells have developed another tolerance mechanism called re-
priming (Figure 6). In this process, the DNA primer is generated from downstream of the 
damaged template. With this manner, cells can skip the replication of damaged template DNA. 
DNA primase-polymerase (PrimPol) plays a central role in this process (Bailey and Doherty, 





Figure 6 DNA damage tolerance mechanism 
 
The scheme of DNA damage tolerance mechanism. Cells utilize translesion DNA synthesis, 




 DNA damage happens not only in daily life but also by therapeutic drugs. Since most cancer 
cells are less tolerant of DNA replication stress or DNA damage, current cancer 
chemotherapies apply DNA damaging reagents. They damage DNA in healthy (non-cancer) 
cells as well. The genetic study allows us to understand the relationship between two or more 
genes. Due to the high frequency of targeted integration rate, gene knockout system in 
Chicken B lymphocyte DT40 cells was established for genetic study in a vertebrate in the 
early ’90s (Buerstedde and Takeda, 1991). In 2013, gene-editing technology using CRISPR-
Cas9 is established for genetic study in a mammal cell lines (Cong et al., 2013). These genetic 
studies contributed to the understanding of genetic relationships between two or more. We 
have the idea that when two or more genes are disrupted at the same time, even if cells can 
proliferate properly under the loss of every single gene, the cell shows lethality. This 
phenomenon is referred to as ‘synthetic lethality’. Cancer cells often lack the function of a 
certain protein related to the genome maintenance, DNA repair and replication. We can 
selectively kill cancer cells by disrupting or inhibiting certain proteins that are in a synthetic 
lethal relationship with the protein lost in cancer.  
 To identify the synergistic relationship, genetic studies are important. Moreover, many 
enzymes work not only in one pathway but also work in several pathways. Inhibition of one 
enzyme can lead to deficiencies in several pathways. Selecting enzymes to inhibit is very 
important to reduce unexpected side effects in cancer-chemotherapy. Therefore, 
understanding of molecular networks in the genome maintenance, DNA repair and 
replication is critical to establish better molecular-targeting chemotherapy. 
 PARP inhibitors, for example, are the most successful targeting cancer chemotherapy drugs 
(Murai et al., 2012; Tutt et al., 2010). PARP inhibitors inhibit the enzymatic activity of PARP 
enzymes responsible for SSB repair, and thereby resulting in accumulated unrepaired SSB. 
Replication across the unrepaired SSB induces DSB during S-phase. Since HR exclusively 
contributes to the repair of this type of lesion, PARP inhibitors selectively kills HR defective 
cancer cells such as BRCA negative cancer. Since non-cancer cells have a normal HR pathway, 
use of PARP inhibitors has limited side effect for patients. Although many companies or 
institutes try to find molecular targeting drugs like PARP inhibitors, few drugs were 






 DNA damage can cause mutation on the genome, leading to disfunction of enzymes. Since 
cellular reactions are strictly controlled by the combination of many enzymes, single 
mutation can induce severe diseases. DNA damage can be caused by many factors, including 
daily products or drugs. We need more information about chemical compounds’ toxicity to 
live safe life. Toxicology is a research field that studies the harmful effects of chemicals. 
Zillions of chemical compounds are produced for clinical use, commercial use, food, etc. 
Some of them can be very toxic. Understanding how chemicals can be toxic is important to 
keep our health safe. 
 Bruce Ames has developed the first genotoxicity assessment system. This assay system uses 
bacteria, which is usually Salmonella Typhimurium. This assay can find out if tested 
compounds have a mutagenic effect or not. Although it is still used for the first screening to 
test compounds’ genotoxicity, it has a high rate of false-positives or false-negatives (Kirkland 
et al., 2014). Since the structure of nuclei and biological systems are deferent between 
bacteria and eukaryotic cells, applying the Ames test for safety tests for the human has been 
a matter of debate. To resolve this problem, a genotoxicity assessment system using gene-
edited chicken B lymphocyte (DT40) was established (Ji et al., 2009). Mutant cells, which 
lack certain DNA repair pathways, and Wild-Type cell (WT) are used in this assay. By 
comparing the sensitivity of each mutant and WT cells, we can assess whether or not tested 
compounds induce DNA lesion. Moreover, if tested compounds are judged to have genotoxic 
potential, we can estimate the type of DNA damages induced by the tested compounds. Since 
this assay applies WT as a negative control, the false-positive and false-negative rate is very 
low. The same assessment system has been developed with human cells (Saha et al., 2018). 
Moreover, we can generate gene-edited cell, which has the same mutation in patients. This 










Quantitative High Throughput Screening in National Institutes of Health 
 
Since numerous chemicals are in the world, we cannot test all of them. To understand the 
toxicity of such an amount of chemicals, we need a great method for prediction of the toxicity. 
To predict the toxicity, we need a better assay system to collect a big amount of the 
toxicological data. The U.S tox 21 program in National Institutes of Health (NIH) aims to 
evaluate hundreds and thousands of chemicals quickly and efficiently. This program has 
utilized a quantitative high throughput screening (qHTS) approach to assess a numerous 
number of chemicals by a series of biologically relevant in vitro assays. 
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Chapter 1:  




1-1-1 The Biological roles of Poly ADP Ribose Polymerase 
 
 Proteins are translated from messenger RNA (mRNA). After the translation, some proteins 
are modified on their amino acids. This modification is referred to as post-translational 
modifications (PTM). PTM contributes to the regulation of protein function, protein 
degradation and protein localization. There are more than 300 types of PTM, including 
phosphorylation, ubiquitylation, SUMOylation, etc. Each PTM is involved in a range of 
essential cellular and biological process. Thus, unregulated PTM loss or gain can cause 
diseases as well as mutations in the genome. 
 
 One of the well known PTMs is Poly ADP-ribosylation (PARylation). PARylation is carried 
by Poly(ADP-ribose) polymerase (PARP)(Burkle, 2001). PARP is one of the target protein 
in cancer chemotherapy, because PARP inhibition has synthetic lethal effect in HR defective 
(or reduced) cancer such as BRCA negative cells. PARP family comprises 17 members. In 
human cells, most of the PARP activity is mefdiated by PARP1 and PARP2 (Yelamos et al., 
2011). The simultaneous depletion of PARP1 and PARP2 causes cell death (Yelamos et al., 
2011). PARP possesses 4 domains, DNA binding domain, a caspase-cleaved domain, an auto-
modification domain, and a catalytic domain (Desroches et al., 2019). When DNA damage 
occurs, especially single-strand breaks, DNA binding domain bind to the DNA and leads the 
conformational shift of PARP itself (Mansoorabadi et al., 2014). This shift allows PARP to 
synthesize PAR by using NAD+ as a substrate. PAR acts as a signal for SSB repair enzymes, 
such as XRCC1, and contributes to the recruitment of repair factors. 
  
 Although it has been believed PARylation by PARP is important during the single-strand 
break repair or base excision repair, other roles of PARP have been uncovered. PARP is not 
only a base excision repair factor but also involved in transcription (Schiewer and Knudsen, 
2014), DNA double-strand break repair or cell cycle regulation (Maya-Mendoza et al., 2018; 
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Wang et al., 2006). For this reason, inhibiting PARP for chemotherapy can cause an 
unexpected side effect. Identifying the genetic network around PARP helps us to understand 
the side effects caused by PARP inhibition. I focused on identifying a roles of PARP enzyme 
in DNA repair. 
 
 
1-1-2 ALC1 and Base excision repair 
  
 ALC1(Amplified in Liver Cancer 1, also known as CHD1L [chromodomain helicase-DNA-
binding protein 1-like]) is a member of the SNF2 superfamily of ATPases(Ahel et al., 2009). 
ALC1 possesses a helicase domain and macro domain (Figure 7). ALC1 is preserved well in 
higher eukaryotes. The homology of the sequence is around 60 - 85% in mouse, chicken, 
zebrafish, and turtle (Table 1). Helicase domain and macrodomain are preserved in all of 
those species (Figure 8). This suggests the importance of ALC1 for all higher organisms. 
Helicase domain functions as chromatin remodeling enzymes (chromatin remodelers). 
Chromatin remodelers induce local reluxation of chromatin structure via eviction or sliding 
of nucleosome. This chromatin configuration changes (tight or reluxed form of chromatin) 
contributes to the regulation of all DNA-related reaction such as transcription and DNA repair. 
Macrodomain recognizes Poly(ADP-ribose) (PAR) in vitro and in vivo (Ahel et al., 2009; 
Karras et al., 2005). The domatin structure of ALC1 suggests a potential role of ALC1 as 
chromtin demodeler working in the downstream of PARP signal pathway. PAR is generated 
by Poly(ADP-ribose) polymerase (PARP), which is activated by single-strand DNA breaks 
(SSB) and gaps. SSB is created during base-excision repair (BER), which removes base 
damage, including oxidation and alkylation on bases. Formation of PAR at chromatin 
proteins in the vicinity of SSB facilitates the recruitment of BER factors to damaged-base 
sites. PARP1 stimulates the chromatin-repositioning enzyme activity of ALC1. Collaboration 
between ALC1 and PARP was also reported in the nucleotide-excision repair of ultraviolet 
light (UV) - induced DNA damage (Pines et al., 2012). Although there are several studies 









Figure 7   
The domain structure of ALC1.  ALC1 possesses the ATPase domain and the Macro domain. 
ATPase domain is required for chromatin remodeling activity. Macrodomain recognizes Poly 





 ALC1 is well conserved in Human, Mouse, Chicken, Green sea turtle, Zebrafish and Pacific 
purple sea urchin. 
 





Mouse Mus Musculus 63.30%
Chicken Gallus Gallus 71.00%
Green sea turtle Chelonia Mydas 84.80%
Zebrafish Danio Retio 72.80%




Figure 8  
 ATPase domain and Macro domain are well conserved in higher eukaryote. Consensus 
sequences for each domain are in red square. The identical amino acids with a human 
sequence are highlighted with yellow. Red boxes indicate the consensus sequence in the 
ATPase domain and Macrodomain. 
 
1-1-3 PARP works together with Tyrosyl DNA Phosphodiesterase 1 
 
 Another remarkable role of PARP is in the tolerance to Camptothecin (CPT)-induced damage 
(Chaudhuri et al., 2012; Sugimura et al., 2008). CPT is a Topoisomerase1 (Top1) poison. 
Each cell has huge genomic DNA sequences (totally approximate 2 meters of DNA). 
Chromatin structure allows DNA to be fit in a small nucleus, the diameter of which is about 
10 μm. During DNA replication, DNA helicases unzip double-strand DNA. Because DNA is 
highly compacted in the nucleus, unzipping by replication machinery causes topological 
stress of DNA. This topological stress needs to be relaxed because replication fork should be 
arrested by this stress. DNA topological stress is resolved by Topoisomerase1 (Top1) during 
DNA replication. Top1 binds to DNA and induces SSB by forming a covalent bond with 3’ 
end of SSB. Top1 mediates DNA nicking, rotation and resealing to resolve DNA topological 
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stress. CPT inhibits resealing step of Top1 mediated reaction and stabilizes Top1-DNA 
covalent complex (Top1-cc) (Figure 9). Since actively replicating cancer cells generally show 






The scheme of TOP1-mediated DNA decatenation. Camptothecin stabilizes the Top1-DNA 
complex during DNA replication. 
 
During replication, progression of replication forks at Top1-cc induces DSB. To suppress this 
CPT mediated DSB formation, replication fork slows via PARP-mediated fork reversal 
mechanism (Figure 10) (Chaudhuri et al., 2012). By fork reversal mechanism, DSB converts 
into SSB and resultant SSB associated with Top1-cc is repaired by Tyrosyl DNA 
Phosphodiesterase1 (Tdp1) and SSB repair pathway (Das et al., 2014). PARP acts with Tdp1 
to remove Top1-cc (Das et al). In the absence of PARP, DNA replication does not slow upon 
CPT treatment, leading to a replication fork collapse (Sugimura et al Chaudhuri et al) . 
Although CPT is approved for cancer chemotherapy, the mechanism of cellular tolerance to 
Top1-cc has not been completely understood.  In this study, I also focused on the role of 
ALC1 in CPT tolerance, because ALC1 possesses macrodomain and PARP works in the 










1-2 Materials  
 
・DT40 strains  
 WT 
 ALC1-/- 










H2O2 (Nacalai, Japan), MMS (Nacalai, Japan), Camptothecin (TopoGEN, Inc.), olaparib 
(AZD-2281, Astrazeneca), etoposide (VP16, Funakoshi), ICRF-193 (Funakoshi) and cis-
diamminedichloroplatinum (II) (cisplatin, Nippon Kayaku) 
 
 
Cell culture medium  
・DT40 
DT40 cell line was obtained from Takeda lab (Kyoto University, Japan). DT40 cells were 
cultured in an RPMI 1640 medium (Nacalai Tesque, Kyoto, Japan) supplemented with 10% 
heat-inactivated fetal bovine serum (FBS), 1% chicken serum, 0.05 mM β-mercaptoethanol, 




TK6 cell line was purchased from JCRB cell bank (http://cellbank.nibiohn.go.jp/english/). 
TK6 cells were cultured in an RPMI 1640 medium (Nacalai Tesque, Kyoto, Japan) 
supplemented with 10% heat-inactivated horse serum (HS) (GIBCO), 0.1 mM sodium 
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1-3 Experimental Method 
・ATPase assay 
106 DT40 cells were exposed to H2O2 and MMS for 1 h in 1 ml culture medium and PBS 
containing 1% fetal bovine serum, respectively. 3 x 104 DT40 cells were exposed to UV in 
30 μl PBS containing 1% fetal bovine serum. TK6 cells were exposed to the two DNA-
damaging agents in the same manner. 10 μl of cell suspensions (containing 104 cells) of the 
exposed DT40 or TK6 cells were plated in duplicate onto 24-well cluster plates containing 1 
ml of the complete medium and were incubated for 48 h (for DT40) and 72 h (for TK6). 1 x 
104 DT40 cells were cultured in 1ml culture medium containing olaparib, etoposide, ICRF-
193 and cis-diamminedichloroplatinum (II) for 48 h. To measure the number of living cells, 
I transferred 100 μl cell suspensions to the individual wells of 96-well plates and measured 
the amount of ATP in the cellular lysates using Cell Titer-Glo (Promega). Luminescence was 
measured with Fluoroskan Ascent FL (Thermo Fisher Scientific Inc., Pittsburgh, PA).  
 
・Colony formation assay 
Cells were cultured in DMEM Ham’s F12 medium supplemented with 15% FBS, 1% chicken 
serum, L-glutamine, 1.5% methylcellulose. DNA damaging reagents were mixed with the 
medium one night before the experiment. Cells were transferred to pre-warmed medium and 
cultured for 1 week. After the formation of colonies, the number of colonies was counted by 
a black marker.  
 
・si-RNA treatment 
HeLa and U2OS cells were cultured in DMEM supplemented with 10% fetal calf serum at 
37 °C. si-RNAs for the depletion of ALC1 and the control were purchased from Thermo 
Scientific (Dhamacon si-RNA, PA). 3 × 105 cells were transfected with 250 pmol si-RNA 
using 10μl Lipofectamine RNAi MAX (Invitrogen, CA). 
 
・Detection of GFP-XRCC1 at the site of SSBs induced by Neurospora crassa UV-damage 
endonuclease (UVDE) 
 U2OS cells expressing Neurospora crassa UV-damage endonuclease (UVDE) and GFP-
XRCC1 or GFP-Polβ were used. UV irradiation causes cyclobutane-pyrimidine Dimer 




・Partial digestion of chromatin DNA with micrococcal nuclease (MNase) 
5 ×107 DT40 cells were pulse-labeled with 20 μM BrdU for 10 min. Cells were then harvested 
and washed and resuspended in medium either with CPT (20 μM) or without CPT and further 
cultured for 15 min. Partial digestion of chromatin DNA with Micrococcal nuclease (MNase) 
was performed as described previously(Hirota et al., 2008), with slight modifications. Briefly, 
the abovementioned BrdU-labeled cells were suspended in 0.5 ml of lysis buffer (18% Ficoll 
400, 10 mM KH2PO4, 10 mM K2HPO4, 1 mM MgCl2, 0.25 mM EGTA, 0.25 mM EDTA) 
containing a proteinase inhibitor cocktail (Complete, Roche). After centrifugation at 14,000 
rpm for 30 min at 4 °C, the crude chromatin fraction was resuspended in 0.3 ml of buffer A 
(10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 5 mM KCl, and 1 mM EDTA) containing a 
proteinase inhibitor cocktail (Complete, Roche). After the addition of CaCl2 (5 mM final 
concentration), 0.1 ml aliquots of crude chromatin suspension were digested with several 
different amounts of MNase (0, 5, 10, and 20 U/ml) at 37 °C for 5 min. The reaction was 
terminated by adding 25 mM EDTA, and DNA was purified. DNA samples were resolved in 
2% agarose gel electrophoresis followed by membrane transfer and immunodetection using 
anti-BrdU antibody (Roche). 
 
Lysis buffer    Buffer A 
18%  Ficol 400   10mM Tris-HCl [pH 8.0] 







・Isolation of nuclear-soluble and chromatin-bound fractions from DT40 Cells 
 I isolated the nuclear soluble fraction from DT40 cells using the Subcellular Protein 
Fractionation Kit for Cultured Cells (Thermo, PA). Histone and Top1 were detected using 
following specific antibodies (anti-Histone H3 from MBL, MABI0301 and anti-Top 1 from 
BD PharmingenTM, 556597). 
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・Measuring the amount of single-strand breaks by Alkaline comet assay 
For the chicken DT40 cells, the tail DNA percentage, reflecting the number of SSBs (% DNA 
in tail), was measured for cells that had been exposed to 25 μM H2O2 for 20 min on ice, and 
cells that had been exposed to 25 μM H2O2 for 20 min on ice followed by a 30 min repair 
period at 39.5 °C. Human TK6 cells were treated with 80 μM H2O2 on ice for 30 min or with 
MMS at 37 °C for 15 min and subsequently released in drug-free, pre-warmed culture 
medium. Cells were harvested at the indicated time after release. 
 After the chemical treatment, individual cells are embedded in a thin agarose gel on a 
microscope slide. After embedding, I lysed the cell to remove all cellular proteins in buffer 
(2.5M NaCl, 100mM EDTA, 10mM Tris-HCl (pH 10), 1% Triton, 0.5% Sarcosine) at 4°C 
for 90 min. Then, I treated the cells under alkaline condition to let DNA unwind. Finally, I 
separated DNA based on the size of DNA by electrophoresis. Electrophoresis was carried out 
by applying 25 volts at 4 °C in running buffer (0.3M NaOH, 1mM EDTA (pH 13)) for 50 
min using a submarine gel electrophoresis machine (Cat. NB-1012, NIHON EIDO CO. Ltd.) 
filled with 1850 ml running buffer. The broken DNA fragments or damaged DNA migrates 
away from the nucleus. After staining with ethidium bromide, a DNA-specific fluorescent 
dye, I took several pictures of DNA. The resulting image looks like a comet as the name of 
the assay indicates. Each comet has a distinct head and tail. The head is composed of intact 
DNA, while the tail consists of single-strand broken DNA. I analyzed the images by using 
Comet Analyzer software. 
 
 
・Chromosomal aberration analysis 
 DT40 clones were treated with 0.06% colcemid (Gibco BRL) for 2.5 h to arrest cells in the 
M-phase. Cells were pelleted by centrifugation, resuspended in 1 ml of 75 mM KCl for 15 
min at room temperature, and fixed in 5 ml of a freshly prepared 3:1 mixture of methanol 
and acetic acid (Carnoy's solution). The pelleted cells were then resuspended in 5 ml of 
Carnoy's solution, dropped onto clean glass slides and air-dried. The slides were stained with 
a 5% HARLECO Giemsa stain solution (Nacalai Tesque) for 10 min, rinsed with water and 
acetone, and dried. All chromosomes in each mitotic cell were scored at 1000 × magnification. 
 
 
・DNA fiber assay 
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Cells (5 x 105 in 1 mL of medium) were pulse-labeled with 25 µM chlorodeoxyuridine (CldU; 
Sigma) and then sequentially pulse-labeled with 250 µM iododeoxyuridine (IdU; Sigma). 
Cells were resuspended in ice-cold PBS and then dropped onto glass slides (MATSUNAMI). 
Cells were lysed with DNA fiber lysis buffer (0.5% SDS, 200 mM Tris-HCl, pH 7.4, 50 mM 
EDTA), and then glass slides were tilted to extend DNA. For fixation, glass slides were 
immersed in Carnoy solution (MeOH: AcOH, 3:1) for 3 min, then 70% EtOH for 1 h to 
overnight. After washing with PBS, glass slides were immersed in 2.5 M HCl for 30 min to 
denature DNA molecules and subsequently in 0.1 M sodium tetraborate for 3 min to 
neutralize the acid. After washing with PBS, the slides were treated with rat anti-BrdU 
antibody (1:200; Abcam) and mouse anti-BrdU antibody (1:50; BD Biosciences), which 
reacted against CldU and IdU, respectively. Cy3- conjugated anti-rat IgG (1:400; Jackson 
Immunoresearch) and Alexa Fluor 488 antimouse IgG (1:100; Invitrogen) were used as the 
secondary antibodies. The first and second antibodies were incubated for 1 h at room 
temperature, respectively. Washing of antibodies was performed with 0.05% Tween 20 in 
PBS. Coverslips were mounted with Shandon* PermaFluor (Invitrogen). Images were 
captured with a fluorescence microscope. Fiber lengths were measured using ImageJ, and 
micrometer values were expressed in kilobases using the following conversion factor: 1 µm 
= 2.59 kb. Measurements were recorded from areas of the slides with untangled DNA fibers 
to prevent the possibility of recording labeled patches from tangled bundles of fibers. 






1-4-1 Analysis of sensitivity profile of ALC1 mutant 
 
 To investigate the role played by ALC1 in BER, I measured sensitivity to base damaging 
reagents, hydrogen peroxide (H2O2) and Methyl MethaneSulfonate (MMS). Once cells 
incorporate H2O2, H2O2 produces hydroxyl radical (•OH) as a result of Fenton's reaction (see 
below). 
Fe2+ + H2O2 → Fe3+ + OH- + •OH 
 
The hydroxyl radical is one of the most reactive oxygen species (ROS). It bonds to DNA and 
causes DNA base damages. It is a by-product of many biological reactions such as 
metabolization. MMS is an alkylating reagent. It mainly binds to guanine or adenine and 
causes base damage as well as H2O2. 
 
 ALC1-/- cells were hypersensitive to both H2O2 and MMS (Figure 10). PARP1-/ cells showed 
higher sensitivity than wild-type does, as reported previously. To learn more about ALC1 as 
a chromatin-remodeling factor, I generated an ATPase-dead ALC1 mutant. The ATPase 
activity is inactivated by mutating the essential E165 to Q of the endogenous wild-type ALC1 
allelic gene in ALC1-/+ cells. ALC1-/E165Q and ALC1-/- cells displayed virtually the same 


















Figure 11  
 The sensitivity profile of WT and ALC1 mutants to H2O2 (left) and MMS (right). Y-axis 






1-4-2 The epistatic analysis between ALC1 and PARP 
 
 To analyze the functional relationship between ALC1 and PARP1, I generated ALC1-/-
/PARP1-/- cells by disrupting the ALC1 gene in PARP1-/- DT40 cells. I analyzed cellular 
sensitivity to H2O2 and MMS by comparing the sensitivity among Wild-type, PARP1-/-, ALC1-
/-, and ALC1-/-/PARP1-/- clones. While the sensitivity of  ALC1-/- and PARP-/- to H2O2 was 
higher than that of Wild-type clones, it was very similar in ALC1-/- and ALC1-/-/PARP1-/- 
clones, indicating an epistatic relationship between ALC1 and PARP1(Figure 12). Moreover, 
ALC1 and PARP1 have an epistatic relationship, as sensitivity to MMS was very similar for 
PARP1-/- and ALC1-/-/ PARP1-/- clones(Figure 12). These observations indicate that ALC1's 
role in cellular tolerance to H2O2 and MMS depends at least partially on the functionality of 
PARP1. In conclusion, given that PARP1 contributes to H2O2 and MMS tolerance by 











The sensitivity profile of indicated cell lines to H2O2 (left) and MMS (right). Y-axis indicates 




1-4-3 The role of ALC1 in Base Excision Repair 
 
 The sensitivity data suggest that ALC1 may facilitate BER cooperating with PARP. I thus 
monitored ongoing BER by measuring the number of SSBs, which are BER intermediates. 
After 20 min of H2O2 treatment on ice, I performed the alkaline-comet assays. Alkaline 
Comet Assay (i.e. single cell gel electrophoresis), is a sensitive technique to quantify DNA 
single-strand breaks in individual cells (Braafladt et al., 2016). Immediately after H2O2 pulse-
treatment, tail sizes in wild-type and ALC1-/- cells were very similar (Figure 13 middle). At 
30 min after treatment, tails in the wild-type cells had decreased to nearly normal size, while 
tails in the ALC1-/- cells were significantly longer (Figure 13 right). Importantly,  ALC1-/-, 
PARP1-/-, and ALC1-/-/PARP1-/- clones all showed similar kinetics in SSB repair. These data 







 Alkaline comet assay to detect SSBs. Indicated cell lines were tested in untreated cells, 
immediately after exposure to 25 μM H2O2 on ice, and after a further 30 min incubation 
(repair period). Error bars represent standard deviations from three independent experiments. 
Tail-DNA percentage, defined as the percentage of damaged DNA (% DNA in the tail), was 
calculated as described in Materials and Methods. Tail-DNA% is displayed on the y-axis on 




 To examine ALC1's role in BER in human cells, I created ALC1-/- clones from the human 
TK6 cell line and analyzed SSB-repair kinetics by performing an alkaline-comet assay in 
Wild-type and ALC1-/- TK6 cells. ALC1-/- TK6 cells were more sensitive to MMS than Wild-
type cells (Figure.15). Unlike the DT40 cells, ALC1-/- TK6 cells showed similar H2O2 
sensitivity compared to Wild-type cells (Figure 14). It is possible that the oxidative stress 
decreased cellular viability through mechanisms other than DNA damage in this cell line. 






The sensitivity profile of indicated cell lines to MMS (left) and H2O2 (right). Y-axis indicates 
the survival % and x-axis indicates the dose. 
 
 
 Nonetheless, delayed SSB repair at 5 min following pulse-exposure to H2O2 was 
reproducibly seen in ALC1-/- TK6 cells (Figure 15A). Moreover, when the pulse-exposed 
cells were subsequently treated with the chemotherapeutic PARP poison, olaparib, which 
stabilizes the PARP-DNA complex, the delay in SSB repair in  ALC1-/- TK6 cells was more 
pronounced than in the wild-type cells (Figure 15 B). I thus conclude that ALC1 contributes 
to SSB repair in the human TK6 cell line as well as in the chicken DT40 cells. I examined 
the kinetics of BER following pulse-exposure to MMS. Note that pulse-exposure to MMS 
has to be done at 37 °C, at which temperature base damage and repair occur in parallel. 
Alkaline-comet tails were longer in ALC1-/- than in Wild-type cells after pulse-exposure to 
MMS, suggesting a BER defect in the ALC1-/- cells. To examine the actual BER kinetics, I 
pulse-exposed Wild-type and ALC1-/- cells to MMS and released them in a drug-free medium. 
Repair in ALC1-/- cells was significantly delayed during the chase period. I thus conclude that 





 Alkaline-comet assay to detect unrepaired SSBs in human TK6 cells. The percentage of 
DNA strand breaks remaining at the indicated time points is displayed on the y-axis on a 
linear scale. Error bars represent standard deviations from three independent experiments. 
(A) Human TK6 cells of the indicated genotype were exposed to 80 μM H2O2 on ice for 30 
min. The cells were released in drug-free, pre-warmed culture medium and further cultured 
for the indicated time. (B) TK6 cells treated with H2O2 as in (A) were released in culture 
medium containing 1 μM olaparib then cultured for the indicated time. (C) Wild-type and 
ALC1-/- TK6 cells were treated with 0.1 and 0.075 mg/ml MMS, respectively, for 15 min. 
Cells were then released in drug-free, pre-warmed culture medium and further cultured for 
the indicated time. p-value was calculated by a student's t-test: p (**) <0.01, (*) <0.05, and 




1-4-4 ALC1 promote BER independently of XRCC1 
 
 I confirmed that ALC1 and PARP1 have an epistatic relationship in BER in chicken DT40 
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cells. I next aimed to define the role played by ALC1 in the promotion of BER by PARP. To 
test whether ALC1 controls PARP-mediated PARylation, I measured intracellular NAD(P)H 
during continuous exposure to H2O2 and MMS. This assay monitors PARP-mediated 
PARylation, since the reduction of NAD+, a major substrate of PARP, results in depletion of 
cellular NAD(P)H. I found that the amount of NAD(P)H was reduced in wild-type and ALC1-
/- DT40 cells with very similar kinetics (Figure 16), indicating that ALC1 does not affect 







 DT40 clones of the indicated genotypes were treated with H2O2 or MMS and harvested at 
the indicated times after treatment. To evaluate the activation of the PARylation event by 
PARP1 at SSB sites, I measured the cellular concentration of NAD(P)H, the major substrate 
for PARP. Time after treatment with H2O2 or MMS is displayed on the x-axis, while the 




I considered that ALC1 might control PARP-mediated recruitment of XRCC1 to damage sites. 
To test this hypothesis, I induced SSBs selectively in subnuclear areas and examined the 
kinetics of XRCC1 re-localization to SSB sites. To induce SSBs, I employed a nucleotide 
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excision repair-deficient xeroderma pigmentosum group A (XPA) U2OS cells expressing 
Neurospora crassa UV-damage endonuclease (UVDE), which generates SSBs at UV 
photoproducts. I depleted ALC1 using si-RNA in HeLa and U2OS cells and monitored the 
recruitment of BER factors to induced SSB sites after UV irradiation. As with the ALC1-/- 
DT40 cells, the ALC1-depleted HeLa cells showed a higher sensitivity to H2O2 than did the 
si-control-RNA-treated cells (Figure 17A). On the other hand, the depletion of ALC1 did not 
impair the recruitment of XRCC1 to induced SSB sites (Figure 17C). Similarly, GFP-XRCC1 
was efficiently recruited to laser-induced DNA damage sites in ALC1-depleted and control 
cells. Moreover, recruited XRCC1 seemed to be functional since GFP-Polβ also accumulated 
at DNA-damage sites (Figure 17C). I thus conclude that ALC1 contributes to BER 










 (A) H2O2 sensitivity of ALC1-depleted or control si-RNA-treated HeLa cells. The dose of 
H2O2 is displayed on the x-axis on a linear scale, while the percentage of cell survival is 
displayed on the y-axis on a logarithmic scale. (B) U2OS cells deficient in nucleotide 
excision repair, xeroderma pigmentosum group A- (XPA-) expressing Neurospora crassa UV-
damage endonuclease (UVDE) were exposed to 100 J/m2 UV through micropores in 
membrane filters. DNA single-strand breaks were produced at the UV-irradiated region, 
where GFP-XRCC1 accumulated independently of ALC1 expression. Representative image 
of XPA-UVDE cells displaying GFP-XRCC1 and UV damage (CPD) signals. (C) GFP-
XRCC1 and GFP-Polβ accumulate immediately at DNA damage sites after exposure to a 405 
nm pulse laser in U2OS cells, which have been treated with siRNA against ALC1 or control 
siRNA for 48 h. GFP-signal intensity for GFP-XRCC1 and GFP-Polβ is displayed in the 
histogram. Error bars represent standard deviations from three independent experiments. p-




1-4-5 ALC1 promotes BER by inducing chromatin remodeling through 
histone eviction 
 
 The above conclusion led me to consider that ALC1 might promote chromatin relaxation at 
DNA-damage sites to facilitate DNA repair. To monitor the extent of chromatin compaction, 
I performed the MNase chromatin digestion assay. MNase tends to digest nucleosomes that 
have reluxed (open) chromatin structure, resulting in a single nucleosome (mononucleosome). 
I exposed chicken DT40 cells to H2O2, then partially digested chromatin DNA with MNase, 
and quantified the fraction of the mononucleosome. Five min after treatment with 5mM H2O2, 
the amount of partially digested product, ~146 bp DNA, was significantly increased in Wild-
type cells, but not in ALC1-/- cells(Figure 18A). The data suggest that the configuration of 
chromatin changes into open status in Wild-type but not in ALC1-/- cells by H2O2-induced 
DNA damage presumably through inducing histone eviction. To further examine this 
possibility, I measured the amount of histone H3 released from the chromatin after DNA 
damage. After H2O2 treatment, histone proteins translocate to nuclear soluble from chromatin 
fraction. The amount of histone H3 in the nuclear soluble fraction was increased in wild-type 
cells after H2O2 treatment(Figure 18B), suggesting that DNA-damage induces histone 
eviction from chromatin. However, histone eviction was not observed in ALC1-/- cells(Figure 
18B). These results suggest that ALC1 promotes BER by inducing chromatin remodeling 








Figure 18  
(A) DT40 cells of the indicated genotypes were treated with H2O2, and cells were harvested at the 
indicated times after H2O2 treatment. The chromatin fraction was digested with 10 and 20 U/ml 
MNase. Digested genomic DNA products were analyzed by gel electrophoresis. The relative intensity 
of the band corresponding to the mono-nucleosome (146 bp, indicated by arrow) was quantified. (B) 
Histone H3 present in the nuclear soluble fraction was detected by western blot. The blot was probed 
with anti-Topoisomerase I (TopI) antibody as a loading control. The relative intensity of the band 
corresponding to histone H3 was quantified and normalized for the level of TopI. p-value was 





From the above data, I conclude ALC1 promotes chromatin relaxation at DNA-damage sites 
to facilitate base excision repair to tolerate base damage.  
  
1-4-6 The role of ALC1 to tolerate CPT-induced DNA damage 
 
To investigate the further role of ALC1 in various DNA-repair mechanisms, I measured cell 
survival after exposure to a wide variety of known DNA-damaging agents. ALC1-/- and wild-
type cells exhibited an indistinguishable sensitivity to cisplatin, UV, VP16, ICRF-193, and 
olaparib, but the ALC1-/- cells were moderately more sensitive to CPT than wild-type cells. 
PARP1-/- cells were critically more sensitive to CPT than wild-type and ALC1-/- cells, (Figure 
19). Moreover, ALC1-/E165Q and ALC1-/- cells showed a virtually identical CPT sensitivity, 
indicating that the chromatin-remodeling activity of ALC1 is required for cellular tolerance 
to CPT(Figure 19). These data indicate that ALC1 is involved in the cellular tolerance to CPT 
as well as PARP. Olaparib is a PARP poison. It stabilizes PARP on the DNA during SSB 
repair and makes PARP toxic. PARP-/- mutant showed less sensitivity to olaparib than wild-













The sensitivity profile of Wild-type and ALC1-/- and PARP-/- mutants to indicated compounds 
and irradiations (upper 7 panels). The sensitivity profile of WT and ALC1 null mutants and 
ALC1 helicase dead mutant to CPT (lower panel). Y-axis indicates the survival % and X-axis 





  I next compared the sensitivity to CPT among Wild-type, ALC1-/-, PARP1-/-, and ALC1-/-
/PARP1-/- cells. The ALC1-/- cells were less sensitive than the PARP1-/- cells, with the PARP1-
/- and ALC1-/-/PARP1-/- cells exhibiting a similar sensitivity (Figure 20). Therefore, I conclude 
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that ALC1 and PARP1 collaborate in contributing to cellular tolerance to CPT as well as 






 The sensitivity profile of indicated cell lines to CPT. Y-axis indicates the survival % and x-
axis indicates the dose. 
 
 
  The sensitivity data suggest that ALC1 has a role to tolerate CPT induced DNA damage. To 
confirm the epistatic relationship between ALC1 and PARP to repair CPT-induced DNA 
damage, I conducted chromosome analysis. In this assay, I can see the DNA damage as breaks 
or gaps in chromosomes under microscopy. ALC1-/-, PARP1-/-, and ALC1-/-/PARP1-/- cells all 
showed an increase in the number of chromosome breaks after exposure to CPT, with the 
PARP1-/- and ALC1-/-/PARP1-/- cells exhibiting a very similar number of chromosome 
aberrations (Figure 21). Note that loss of PARP1 in ALC1-/- cells changed the type of 
chromosome aberrations and resulted in an increase of iso-chromatid breaks (i.e., breaks at 
the same site of both sister chromatids.) This type of break is likely caused by the defective 
resolution of recombination intermediates and thus implying a possible involvement of 






(right) Representative images showing DT40 chromosomes. The yellow, red and black 
arrows indicate chromatid breaks, isochromatid breaks and radial chromosomes, respectively. 
(left) The number of chromatid breaks, isochromatid breaks, and radial chromosomes in 50 
mitotic cells. Chicken DT40 cells were exposed to CPT (10 nM) for 8 h with colcemid added 
2.5 h before harvest to accumulate mitotic cells. Error bars represent standard deviations from 
three independent experiments. 
 
 
1-4-7 ALC1 promotes chromatin relaxation around DNA replication to 
tolerate CPT-induced DNA damage 
 
 
 The requirement of ALC1’s ATPase activity for tolerance to CPT suggests that ALC1 might 
induce chromatin relaxation around Top1-cc. To examine this hypothesis, I analyzed the 
degree of chromatin condensation around the replication forks stalled at Top1-cc using an 
MNase digestion assay. I modified this assay to see the event around replication fork. I 
labeled newly replicated DNA with BrdU for 10 min and I treated the cells with CPT for 15 
min, then detected it with an anti-BrdU antibody. The partially digested product 
corresponding to mono-nucleosomes was quantified. Following treatment with 20 μM CPT, 
MNase sensitivity was significantly increased and mono-nucleosomes were more efficiently 
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digested in wild-type cells (Figure 22), suggesting a change of chromatin state into a more 
open configuration. In marked contrast, MNase sensitivity in ALC1-/- cells was slightly 
reduced by the CPT treatment (Figure 22), suggesting that chromatin relaxation around the 
Top1-cc site cannot be maintained in the absence of ALC1. I thus conclude that CPT induces 
chromatin de-condensation and that ALC1 might be required for this process. This conclusion 
is consistent with the recently demonstrated pivotal role played by ALC1 in chromatin 






Nucleosome assembly near Top1-cc. 5 ×107 wild-type and ALC1-/- cells were pulse-labeled 
with BrdU for 10 min followed by treatment with CPT (20 μM) for 15 min. Nuclei were 
prepared and treated with 5, 10, and 20 units/ml MNase for 5 min. DNA was resolved in 2% 
agarose gel and stained with ethidium bromide (EtBr) (upper left panel), transferred onto a 
membrane, and detected with an anti-BrdU antibody (lower left panel). The blue box 
indicates the quantified band corresponding to the mono-nucleosomes. P-value was 
calculated by Student's t-test (*P<0.05).  
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1-4-8 ALC1 does not suppress toxic NHEJ above CPT 
 
 RNF8-/- cells showed a higher sensitivity to CPT than Wild-type cells as well as ALC1-/- and 
PARP1-/-. It is reported that RNF8 suppresses toxic non-homologous end-joining (NHEJ), as 
evidenced by the increased number of radial chromosomes in the RNF8-/- cells. This 
phenomenon occurs mainly because of aberrant NHEJ, as the number of radial chromosome 
events in NHEJ-deficient KU70-/- cells is lower than that in Wild-type cells. To examine 
whether the collaborative ALC1-PARP pathway also contributes to CPT tolerance by 
suppressing toxic NHEJ, I measured the number of radial chromosomes. Radial 
chromosomes are a result of toxic NHEJ. There was no increase in radial chromosomes in 
either ALC1-/- or PARP1-/-, whereas the number of radial chromosomes in RNF8-/- was two 
times higher than in wild-type cells (Figure 23), consistent with the previous report. I thus 
conclude that the ALC1-PARP pathway contributes to CPT tolerance by some other 
mechanism(s) than the suppression of toxic NHEJ. This conclusion is consistent with a 
previous study, which showed that RNF8 and RAD18 collaboratively suppress toxic NHEJ 









The number of radial chromosomes in 50 mitotic cells. DT40 cells were exposed to CPT 
(100nM) for 8 h with colcemid added 2.5 h before harvest to accumulate mitotic cells. Error 
bars represent standard deviations from three independent experiments. P-value was 
calculated by a Student's t-test (*P<0.05); n.s. = not significant. 
 
1-4-9 ALC1 prevents replication-fork collapse by slowing fork progression 
 
 Since CPT induces replication-fork slowing, I next examined roles played by ALC1 in fork 
slowing upon CPT. To observe the replication fork progression, I carried the DNA fiber assay. 
In this assay, I added two types of nucleotide analogs, CldU and IdU in culture medium. 
Replicating cells incorporate them in replicated tracts, and the replicated tracts can be 
separately stained by specific antibodies. I measured the length of the replicated tracks before 
(CldU) and after (IdU) CPT treatment in ALC1-/-, PARP1-/, and wild-type cells, then 
compared the CldU/IdU ratios (Figure 24). Consistent with the previous study (Chaudhuri et 
al., 2012; Sugimura et al., 2008), replication tracts in the wild-type cells were significantly 
shortened following CPT exposure, with a median CldU/IdU ratio of 2.29± 0.15. In ALC1-/- 
cells, replication-fork slowing was partially impaired, with a median CldU/IdU ratio of 1.77± 
0.08. PARP1-/- cells showed an even more pronounced defect in replication-fork slowing 
(median CldU/IdU ratio of 1.29± 0.01) (Figure 24). These results indicate that ALC1 is 







 (upper left) Representative images showing stained DNA fibers. DT40 cells were labeled 
sequentially with CldU and IdU with or without CPT treatment after CldU labeling.  
Distribution of CldU/IdU ratios for replication forks in cells exposed to CPT. Indicated cells 
were incubated in medium containing CldU (25 μM) for 15 min, then incubated in medium 
containing IdU (250 μM) with CPT (10 μM) or without CPT for 15 min. The CldU/IdU ratios 
are shown on the x-axis. The number of fibers in each section is shown on the y-axis. 100 
forks from each cell line were analyzed. Error bars represent standard deviations from three 




The critical role played by the PARP pathway in safe fork slowing and the data showing an 
epistatic relationship between ALC1 and PARP1 in CPT tolerance combine to suggest that 
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1-5-1 ALC1 works with PARP as a chromatin remodeler in the base 
excision repair but independent of XRCC1 
 
 During the past decade, roles played by ALC1 in the regulation of DNA repair, as well as its 
PARP1 stimulated chromatin-repositioning enzyme activity, have been well determined 
(Ahel et al., 2009; Pines et al., 2012). 12 proteins are found to have macrodomain so far. 
ALC1 is the only protein that possesses both macrodomain and ATPase domain, suggesting 
the uniqueness of ALC1.  
 
In this study, I explored ALC1's possible role in BER in the chicken DT40 and human TK6 
cell lines and a genetic relationship with PARP. In viability assay, ALC1-/- cells show high 
sensitivity to both MMS and H2O2. I demonstrated the epistatic relationship between ALC1-
/- and PARP1-/- mutants in cellular resistance to H2O2 and MMS in chicken DT40 cells. The 
epistatic relationship between ALC1-/- and PARP1-/- is consistent with the previous reports 
showing that ALC1 is recruited to the site of DNA damage and activated through PARylation. 
Since PARP1 plays a role in BER, this epistatic relationship further supports the conclusion 
that ALC1 plays a role in BER. In Alkaline-comet assays, which measures SSB which is an 
intermediate of BER, ALC1-/- showed higher amount of SSB than wild-type cells in both 
chicken and human cells. It suggests that ALC1 promotes BER after SSB formation. The 
results were consistent with the previously suggested possible roles of ALC1 in DNA repair. 
However, in human cells, ALC1-/- cells did not show a higher sensitivity to H2O2. Even so, 
ALC1-/- TK6 cells showed a higher amount of SSB at 5min after H2O2 pulse treatment. Given 
that ALC1-/- almost complete SSB repair at 15min after H2O2 treatment, base excision repair 
is a very quick reaction and ALC1 may works within 5 minutes after SSB occurs. This is 
possible that another repair mechanism can repair H2O2-induced DNA damage in long term 
repair. This may be the reason ALC1-/- TK6 cells did not show sensitivity in viability assay.  
 
The data reveal that ALC1 contributes to the PARP-dependent promotion of BER without 
affecting the recruitment of XRCC1 or Polβ to DNA lesions. I thus conclude that ALC1 plays 
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a key role in BER repair, independent of both XRCC1 and Polβ. How ALC1 contribute to 
BER is still controversial. A significant delay in the repair of SSBs, which are BER 
intermediates, indicates that ALC1 contributes to promoting the sealing of SSBs downstream 
of PARylation. ALC1 facilitates chromatin relaxation, most likely at DNA damage sites. This 
is consistent with the fact that attenuation of ALC1's ATPase activity by the E165Q mutation 
completely inactivates its functions, which is shown as a viability assay. There are two 
choices after SSB  formation during BER. One is short-patch BER and long-patch BER. One 
possible explanation is that chromatin remodeling by ALC1 might facilitate long-patch repair 
by removing nucleosomes for DNA-repair synthesis by DNA polymerases. Future research 
is indicated to clarify ALC1's role in BER by conducting in vitro BER in a chromatin context. 
 
 
1-5-2 ALC1 prevents replication-fork collapse by slowing fork progression 
 
 I also uncovered a previously unappreciated function of ALC1 in the regulation of DNA 
replication, wherein ALC1 slows replication-fork progression at Top1-cc under the PARP 
pathway and thereby prevents replication-fork collapse. This conclusion is supported by a 
DNA-fiber assay demonstrating that ALC1 slows the progression of replication forks after 
CPT treatment. These data unveil the role played by ALC1 in the regulation of replication-
fork progression following DNA damage. ALC1 contributes to cellular tolerance to DNA 
damage through multiple mechanisms: promotion of base-excision-repair pathways and 
prevention of DNA replication-fork collapse following DNA damage to template strands. 
 
 How ALC1 contribute to the regulation of DNA replication is not clear. It is possible that, 
during fork-slowing, some aspect of the PARP-ALC1 axis is under the control of the S-phase-
checkpoint pathway that comprises ATR-Chk1 (Saldivar et al., 2017). Top1-cc interferes with 
DNA replication by avoiding origin firing and fork progression via the ATR-Chk1 signal 
pathway (Seiler et al., 2007). One possible scenario is that transient replication-fork arrest at 
Top1-cc sites activates the ATR-Chk1 checkpoint, which in turn activates the PARP-ALC1 
axis, leading to fork reversal in which the newly synthesized strands are annealed to one 
another. This hypothesis is supported by previous reports that visualize fork reversal at Top1-
cc and other DNA damage sites on template strands using an electronic microscope 
(Chaudhuri et al., 2012; Zellweger et al., 2015). Fork reversal might also require homologous 
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recombination mechanisms, including the RAD51-XRCC3 complex (Henry-Mowatt et al., 
2003). As a result of fork reversal for the safe replication fork slowing, Top1-cc at the 3' SSB 
end might be efficiently excised by nucleases including TDP1. Besides, removal of CPT 
allows Top1-mediated re-ligation (Pommier, 2006, 2009). Loss of fork reversal and following 
lethal replication may result in one-end DSB at fork leading to fork collapse.  
 
 
1-5-3 Overexpression of ALC1 and cancer development 
 
 The ALC1 gene is frequently amplified and overexpressed in human hepatocellular 
carcinoma and numerous solid tumors. This overexpression is associated with lymph node 
metastasis, tumor differentiation, and distant metastasis, suggesting that the ALC1 gene plays 
a role in invasion and metastasis of cancer cells. In contrast to the hypoxic microenvironment 
of solid tumors, malignant cells are exposed to a high concentration of oxygen during 
hematogenous metastasis. This study revealed that ALC1 induces chromatin remodeling 
around damaged bases. A liver is responsible for the metabolization process. Metabolization 
causes ROS. ROS activates ALC1. One possible explanation for the connection between 
overexpression of ALC1 and cancer development is that overexpressed ALC1 induces 
aberrant chromatin remodeling and thereby causes unscheduled enzymatic reactions, 












Chapter 2:  
Warsaw breakage syndrome DDX11 helicase acts jointly with 
RAD17 in the repair of bulky lesions and replication through 





2-1-1 Warsaw Breakage Syndrome and DDX11 
 
There are approximately 7,000 rare diseases reported. The definition of the rare disease 
depends on countries. In the US, it is defined as a condition that affects fewer than 200,000 
people. 80% of rare diseases are considered to be related to genetic mutations on a specific 
gene (https://globalgenes.org/).  
 
Warsaw breakage syndrome (WABS) is one of the rare diseases. There are only 14 cases have 
been reported by 2019 (Bottega et al., 2019). Because of a few numbers of the patients, 
molecular mechanisms underlying WABS have not been elucidated. Patients with this disease, 
however, have symptoms of severe growth retardation, microcephaly, intellectual disability, 
and deafness. WABS is caused by biallelic mutations in the DDX11 gene (Bailey et al., 2015; 
Capo-Chichi et al., 2013).  
 
 DDX11 gene encodes DDX11 helicase (also known as CHDR1). Helicase enzyme catalyzes 
unwinding of duplex DNA. DDX11 is conserved from yeast to human (Figure 25). In 
addition to the role played by DDX11 as helicase enzyme, role(s) of DDX11 is suggested, 
since DDX11 directly interacts with replication factors, such as proliferating cell nuclear 
antigen (PCNA) and Ctf18-replication factor C (RFC) complex (Bharti et al., 2014a; Farina 
et al., 2008). PCNA is an essential protein for DNA replication. The main role of PCNA is to 
clamp replicative polymerases on duplex DNA for efficient DNA synthesis (Moldovan et al., 
2007). When replication machinery encounters DNA damage and the replication is halted, 
the other polymerase sliding clamp, Rad9-Hus1-Rad1 (9-1-1) complex is loaded around 
DNA by the Rad17-RFC and Ctf18-RFC clamp loader (Karras et al., 2013; Lim et al., 2015). 
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9-1-1 complex promotes ATR-mediated phosphorylation and activation of checkpoint kinase 
1 (Chk1) (Lim et al., 2015). Chk1 is responsible for checkpoint activation and stabilization 
of stalled replication fork. Although it has been suggested that DDX11 plays a role in the 
tolerance to DNA replication stress, the role of DDX11 in the replication has not been studied 
well. Moreover, the cells from WABS patients show a similar phenotype to that from Fanconi 
anemia patient (Bharti et al., 2014b; Eppley et al., 2017). However, the relationship between 




Figure 25 DDX11helicase is conserved in eukaryotic cells 
 
DDX11 is well conserved from S.cerevisiae to Homo sapience 
 
2-1-2 Fanconi anemia  
 
 Fanconi anemia (FA) is one of the hereditary disorders. FA patients tend to have bone 
marrow failure, developmental abnormalities and predisposition to cancer(Ceccaldi et al., 
2012; Ceccaldi et al., 2016b). There are 22 proteins reported to complement FA disorder. 
Those proteins are referred to as Fanconi anemia complementation group (FANC) proteins. 
FANC proteins are essential to repair complicated DNA lesions such as Inter-strand cross-
link (ICL) (Figure 26) (Ceccaldi et al., 2016b; Kottemann and Smogorzewska, 2013). The 
central components of the FA pathway, FANCD2 and FANCI interact with each other and 
are monoubiquitylated by the FA core complex(Ishiai et al., 2008). FANCD2–FANCI 
ubiquitylation promotes lesion unhooking, causing the formation of a gapped DNA molecule 
with the unhooked lesion in the gapped part and a double-strand break (DSB). The DNA 
damage is repaired subsequently by TLS and HR. The FA pathway is strongly linked to the 














Figure 26 The role of FA-pathway in ICL repair 
 When DNA interstrand cross link occurs, FA core complex recognizes the damage and 
accumulates on the damage site. FANC D2/I complex is ubiquitylated by the complex. 
Ubiquitylated FANC D2-I complex promotes resection on the damaged site, leaving DNA 
double strand break on one strand and DNA adduct like damage on the other strand. DNA 
gap carrying DNA adduct like damage is filled-in by Translesion DNA synthesis. The DNA 
double strand break is repaired by homologous recombination by using newly synthesized 
DNA. 
 
2-1-3 DNA damage during DNA replication 
 
 Maintaining genome information is very important for all livings. DNA lesions encountered 
during DNA replication may collapse the stability of replication forks and are an important 
source of DNA replication stress. For example, alkylation on DNA causes stalled replication 
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forks. To avoid replication fork collapse, cells are equipped with multiple tolerance 
mechanisms for replication stresses. One is translesion DNA synthesis (TLS). When 
replication machinery encounters damaged DNA, the replication polymerases are replaced 
with TLS polymerases. TLS polymerase can synthesize DNA over damaged DNA in return 
for accuracy. Another one is template switching. Template switching employs many HR-
related proteins. Stalled newly synthesized DNA invades the sister chromatid and continues 
synthesizing by using sister chromatid as a template. Since the correct DNA sequence is used 
as a template in this process, TS is considered as an error-free pathway. 
In addition to TLS and TS, cells have developed another tolerance mechanism called re-
priming. In this process, DNA primer is generated right next to the damaged DNA. Cells can 
skip the replication on damaged DNA. DNA primase-polymerase (PrimPol) plays a central 
role in this process (Bailey and Doherty, 2017; Kobayashi et al., 2016). 
 
In this study, I investigate the role of DDX11 in the tolerance to DNA replication stress, and 
the relationship between DDX11 and FA proteins, DDX11 and other proteins, which work to 



















Assessment of Cell Growth and Sensitivity to DNA damaging Agents 
Cells were cultured at 39.5 °C in D-MEM/F-12 medium (Gibco) supplemented with 10% 
fetal bovine serum, 2% chicken serum (Sigma), Penicillin/Streptomycin mix, and 10 µM 2-
mercaptoethanol (Gibco). To plot growth curves, each cell line was cultured in three different 
wells of 24 well-plates and passaged every 24 h. The cell number was determined by flow 
cytometry using plastic microbeads (07313-5; Polysciences). Cell solutions were mixed with 
the plastic microbead suspension at a ratio of 10:1, and viable cells, determined by forward 
scatter and side scatter, were counted when a given number of microbeads was detected by 
flow cytometry. To assess drug sensitivity, 1 x 104 cells were cultured in 24-well plates 
containing various concentrations of DNA damaging agents in 1 ml of medium in duplicate. 
Cell viability was assessed after 48 h by flow cytometry using plastic microbeads. Percent 
survival was determined by considering the number of untreated cells as 100%. To determine 
CDDP and MMS sensitivity by Colony survival assay, 4 × 102 cells were inoculated into 60-
mm dishes containing various concentrations of drug in a medium supplemented with 1.5% 
(wt/vol) methylcellulose, 15% fetal bovine serum, and 1.5% chicken serum. Colonies were 
counted after 7–14 days and the percent survival were determined relative to the number of 
colonies of untreated cells. 
 
DNA Transfection and RT-PCR 
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DNA transfection and RT-PCR were performed as described previously. Drug-resistant 
colonies were selected in 96-well plates in medium containing 0.5 µg/ml puromycin, 30 
µg/ml blasticidin, 1 mg/ml L-histidinol, 10 µg/ml mycophenolic acid, 2 mg/ml geneticin, 1 
mg/mL bleomycin, or 2.5 mg/ml hygromycin B, as appropriate. Gene disruption was verified 
by genomic PCR and RT-PCR. The primers used for RTPCR are available upon request. 
 
Visualization of RAD51 and γH2AX subnuclear foci 
After MMC exposure (500 ng/mL, 1h), cells were harvested and spun onto glass slides using 
Cytospin. Cells were pre-permeabilized with 0.1% (v/v) Triton X-100 in in PBS, fixed with 
4% paraformaldehyde and permeabilized with 0.5% (v/v)) Triton X-100 in PBS. Slides were 
then incubated with anti-Rad51 antibodies (Santacruz; sc-8349) and anti-γH2AX antibodies 
(Millipore; 05-636). Alexa-Fluor 488 goat anti-rabbit IgG (Invitrogen) and Cy3- conjugated 
donkey anti-mouse IgG (Jackson ImmunoResearch) were used as secondary antibody and 
0.1 µg/mL DAPI was used for counterstaining. We only scored RAD51- and γH2AX-foci 
positive and negative cells with non-apoptotic nuclei. Images were captured with a 
fluorescent microscope (BX51, OLYMPUS).  
 
AID overexpression by retrovirus infection 
AID overexpression was carried out as described previously. Several single colonies were 
obtained from WT and each mutant. The cells which are overexpressing AID were cultured 
for 2 weeks. AID overexpression was carried out by infection of retrovirus containing the 
AID gene and the internal ribosomal entry site (IRES) followed by the Green fluorescent 
protein (GFP) gene. The efficiency of infection was about 60%, as measured by GFP 
expression. 
 
sIgM gene conversion assay 
The Ig gene conversion assay was carried out as described previously. DT40 has a frameshift 
in its rearranged V segment, which can be repaired by homologous pseudogene sequences. 
IgM negative cells from each genotype were cultured for 2 weeks. After collecting the cells, 
cells were treated with FITC-conjugated α-IgM antibody (BETHYL) and washed by SB 
(PBS containing 1% BSA). After that, cells were resuspended in SB. Cells were analyzed for 




Analysis of IgVλ diversification 
Genomic DNA was extracted at 14 days post-infection. Using primers CVLF6 5’- 
CAGGAGCTCGCGGGGCCGTCACTGATTGCCG and CVLR3 5’- 
GCGCAAGCTTCCCCAGCCTGCCGCCAAGTCCAAG, the rearranged V segments were 
PCR amplified, with Prime Star GXL DNA polymerase (Takarabio, Shiga, Japan), a high 
fidelity thermostable polymerase, cloned into pTOPOII-Zeroblunt (Invitrogen, CA) and 
sequenced with the M13 forward (−21) primer. Sequence alignment with clustalW 
(GenomeNet, Kyoto, Japan; https://www.genome.jp/) allowed identification of changes from 
the parental sequences in each clone. After the alignment, mutations were classified into 








2-3-1 DDX11 Helicase Facilitates Repair and Averts Genomic Instability 
Induced by ICLs 
 
 To explore the role of DDX11 in vertebrate cells, I established DT40 DDX11 knockout cell 
lines (DDX11-/-). I tested the sensitivity to cisplatin (CDDP), which causes intra- and inter-
strand crosslinks (ICLs). DDX11-/- cells are hypersensitive to cisplatin CDDP. The sensitivity 
of DDX11-/- mutants is complemented by expressing chicken and human DDX11, but not by 
expressing a helicase-dead, K87A variant of chicken DDX11 (cDDX11) (Figure 27). In 
similar trends with FA mutants, such as FANCC-/- and FANCJ-/-, DDX11-/- cells are defective 






The sensitivity profile of indicated cell lines to CDDP and MMC. Y-axis indicates the 
survival % and x-axis indicates the dose. 
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Moreover, after exposure to MMC, the frequency of chromosome abnormalities was 
increased, especially regarding chromatid breaks (Figure 28). Thus, DDX11 might play 
pivotal role to avoid genome instability caused by ICLs. 
 
Figure 28 
 The representative picture of chromosome aberrations (Left). The number of chromosome 
aberrations after MMC treatment (Right).  
 
2-3-2 DDX11 Functions as Backup to the FA Pathway in ICL Repair. 
 
 To examine the phenotypic relationship between DDX11 and the FA pathway, I carried out 
a sensitivity assay using double deletion mutant cell, in which both DDX11 and FANCC are 
knocked-out. FANCC is an FA core component required for FANCD2–FANCI ubiquitylation. 
While DDX11-/- cells showed slight sensitivity, FANCC-/ cells showed higher sensitivity than 
DDX11-/- cells. Moreover, DDX11-/-/FANCC-/ cells exhibited much greater sensitivity to 
cisplatin and MMC than either single mutant (Figure 29). Thus, DDX11 is important for ICL 







The sensitivity profile of indicated cell lines to CDDP and MMC. Y-axis indicates the 
survival % and x-axis indicates the dose. 
 
 
2-3-3 DDX11 Facilitates DNA Repair by Homologous Recombination 
 
 The FA pathway is required for cellular tolerance to metabolic formaldehyde (Kottemann 
and Smogorzewska, 2013), which causes DNA adducts as well as ICLs. DDX11-/- cells 
showed slight sensitivity to formaldehyde but DDX11-/-/FANCC-/- cells showed the much 
stronger sensitivity than FANCC-/- mutants did. I also tested double mutants between DDX11 
and FANCJ, as FANCJ is the main helicase associated with the FA pathway (Cota and Garcia-
Garcia, 2012), and both DDX11 and FANCJ are orthologs of budding yeast Chl1. DDX11-/-
/FANCJ-/- cells showed slow proliferation and exhibited synergistic sensitivity to 
formaldehyde (Figure 30), suggesting compensatory functions of DDX11 and FANCJ in 
proliferation and DNA repair. Thus, DDX11 is dispensable for the FA pathway and acts as a 






The cell proliferation curve of the indicated cell lines (Left). The sensitivity profile of 




 In previous reports, DDX11 helicase is required to provide resistance against the PARP 
inhibitor, olaparib (Stoepker et al., 2015), which causes lesions that are repaired primarily by 
HR. To further investigate connections with HR, I carried out sensitivity assay using DDX11-
/-/BRCA2-/-. BRCA2 is critical for HR and also implicated in FA (Prakash et al., 2015). 
DDX11-/-/BRCA2-/- mutants showed additive sensitivity in regard to cellular tolerance to both 






The sensitivity profile of indicated cell lines to CDDP and Olaparib. Y-axis indicates the 
survival % and x-axis indicates the dose 
 
 These results suggest a role for DDX11 in a repair mechanism that responds to olaparib but 
the role presents distinct features from the BRCA2- and FA core-mediated pathways. DDX11-
/- cells are sensitive to the UV mimetic 4NQO (Figure 32), suggesting general roles of DDX11 





The sensitivity profile of indicated cell lines to 4NQO. Y-axis indicates the survival % and 




 Since many HR-related FA factors contribute to DSB repair, I carried the sensitivity assay 
to DSB-inducing reagents. DDX11-/- cells display sensitivity toward drugs that cause 
topological stress and ultimately induce DSBs, such as Camptothecin (CPT), bleomycin, and 







The sensitivity profile of indicated cell lines to CPT and bleomycin and etoposide. Y-axis 
indicates the survival % and x-axis indicates the dose. 
 
 
 To examine whether DDX11 may contribute to HR repair by affecting the recruitment of 
RAD51, I measured RAD51 foci after a short treatment with MMC, followed by recovery. 
Notably, RAD51 foci were decreased in DDX11-/- mutants compared with wild-type control 








RAD51 focus formation after MMC treatment. The scheme for harvesting the cells (upper 
left). The representative image of the cells (upper right). Nuclei containing more than four 
bright foci were defined as foci positive and at least 200 cells were scored for each 
preparation (lower panel). The error bars indicate SD from three independent experiments. 
 
 
To further address a possible role for DDX11 in endogenous recombination-mediated 
processes, I examined its role in Ig gene conversion, measured as the gain of surface IgM 
(sIgM) expression. DT40 cells carry a frameshift mutation in the Ig light-chain variable 
(IgVλ) segment, but gene conversion from pseudo-V segments removes the frameshift 
mutation, causing sIgM expression. WT and DDX11-/- clones were expanded for 14 d from 
single clones, in the absence or presence of trichostatin A (TSA), a histone deacetylase 
inhibitor that increases the frequency of Ig gene conversion in DT40 cells (Seo et al., 2005; 
Lin et al., 2008), thus allowing detection of rare gene-conversion events. In both spontaneous 
and TSA conditions, DDX11-/- mutants showed significant reduction in the frequency of Ig 






The scheme of sIgM assay of gene conversion (Left) and the rate of sIgM-positive cells 
(Right). In the box plots, the middle line indicates the median value; the box shows the 25th 
and 75th percentiles; the bars, the 5th and 95th percentiles. P values were calculated by 
Student’s t test. **P ≤ 0.01, ****P ≤ 0.0001. 
 
Taken together, these data suggest that DDX11 facilitates HR repair of PARP poison and ICL 
and gene conversion at the IgV region. 
 
 
2-3-4 DDX11 Acts Jointly with 9-1-1 to Facilitate Post-replicative DNA 
Repair 
  
To address whether DDX11 works at the replication fork, I tested the sensitivity of DDX11-/- 
mutant to aphidicolin and hydroxy urea (Figure 36). I did not observe significant differences 
between wild-type and DDX11-/- cells in either condition. Moreover, DDX11 is not essential 
for replication fork stability, as deduced from the lack of sensitivity of DDX11-/- cells to 
aphidicolin, a DNA polymerase inhibitor. Taken together, these results suggest that DDX11 






The sensitivity profile of indicated cell lines to Hydroxy Urea and Aphidicolin. Y-axis 




 Because PrimPol has been implicated in reinitiating replication upon different types of 
replication lesions in eukaryotic cells (Bailey and Doherty, 2017; Kobayashi et al., 2016), I 
also generated DDX11-/-/PRIMPOL-/- double mutants. These mutants showed additive 
sensitivity toward cisplatin and MMS (Figure 37), suggesting that DDX11 affects a step in 
DNA damage tolerance that is distinct from the replication restart step and TLS functions 





The sensitivity profile of indicated cell lines to CDDP and MMS. Y-axis indicates the 




 The 9-1-1 checkpoint clamp promotes HR and facilitates repair of various types of 
replication lesions. The 9-1-1 checkpoint clamp is activated by ICLs, bulky adducts, and 
ssDNA gaps (Lim et al., 2015; Saberi et al., 2007). Because these features overlap what I 
found here for DDX11-/-, I analyzed the functional interaction between DDX11 and 9-1-1. 
Strikingly, I found epistasis between DDX11 and the 9-1-1 checkpoint clamp loader, RAD17, 





The sensitivity profile of indicated cell lines to CDDP and MMS. Y-axis indicates the 
survival % and x-axis indicates the dose. 
 
 
Next, I tested whether the lesions remaining in DDX11-/- and RAD17-/- cells are amenable 
to post-replicative HR repair, a pathway induced by improving sister chromatid cohesion 
(SCC) in G2/M, after the bulk of DNA replication is complete. I improved post-replicative 
SCC by inhibiting a prophase pathway of cohesion release relying on Plk1-mediated 
phosphorylation of the cohesion subunit, SA2 (Hauf et al., 2005). SA2 has 12 serine/ 
threonine residues which are the targets of Plk1-mediated phosphorylation. The 
phosphorylation on the serine/ threonine residues are responsible for cohesion dissociation. 
The phosphorylation on SA2 is suppressed by mutating the serine/threonine residues to 
alanine (SA2-12A mutant) (Hauf et al., 2005). I found that expression of SA2-12A can partly 
rescue the sensitivity of DDX11-/- and RAD17-/- cells to cisplatin and MMS (Figure 39). Thus, 
the lesions accumulating in DDX11-/- and RAD17-/- cells can be repaired post-replicatively by 





The sensitivity profile of indicated cell lines to CDDP and MMS. Y-axis indicates the 
survival % and x-axis indicates the dose. 
 
 
Next, I tested whether DDX11 and 9-1-1 play similar or distinct roles in averting genome 
instability induced by MMC. Defects in RAD51 focus formation and accumulation of 
γH2AX foci following MMC treatment appeared similar in DDX11-/-, RAD17-/-, and DDX11-
/-/RAD17-/- double mutants (Figure 40). In all, these results indicate that DDX11 and 9-1-1 






RAD51 and γH2AX focus formation in cells of the indicated genotype following MMC 





2-3-5 DDX11 Facilitates Ig Hypermutation and Gene Conversion 
 
 To better analyze the in vivo role played by DDX11 at endogenous abasic sites, and its 
relationship with RAD17, I examined the diversification of the IgVλ region in WT, DDX11-
/-, RAD17-/-, and DDX11-/-/RAD17-/- mutants overexpressing AID, required for programmed 






 The scheme of IgVλ diversification assay. 
 
I sequenced IgVλ gene libraries from expanded clones and analyzed the contributions of 
TLS-mediated hypermutation and HR-mediated gene conversion in this process. In a similar 
trend with RAD17-/-, and in line with the sIgM assay of gene conversion, I found a reduction 
in gene conversion events in DDX11-/- cells compared with WT. The reduction in gene 
conversion events was stronger in RAD17-/- cells, and in line with previous reports (Saberi et 
al., 2008), and DDX11-/-/RAD17-/- showed similar trends with RAD17-/- mutants (Figure 42). 
RAD17-/- mutants compensate for the reduction in gene conversion by increasing 
hypermutation, similarly with mutations in RAD51 paralogues. Interestingly, DDX11-/- 
mutants showed reduction in both hypermutation and gene conversion, and the strongly 
increased hypermutation events in RAD17-/- cells depended in large part on DDX11. These 
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Figure 42  
  Rate of gene conversion (GC) and hypermutation (PM) (upper panel). The scheme of GC 






2-4-1 DDX11 works as a backup for Fanconi anemia pathway in the repair 
of DNA inter strand crosslink 
 
The importance of the FA pathway in repairing complex lesions such as ICLs is now well 
established. The existence of genetic disorders that have clinical and cellular overlaps with 
FA indicates the presence of pathways that can compensate in certain contexts for FA and/or 
act on other types of endogenous lesions. Our study highlighted that one such pathway is 
defined by the highly conserved DDX11/ChlR1 helicase mutated in the WABS genetic 
disorder. The cells deficient in DDX11 showed high sensitivity to ICL inducing reagent as 
well as FA protein mutant. However, the sensitivity was lower in DDX11 mutant than in FA 
mutant and knockout of DDX11 strongly enhanced the sensitivity in FA mutants, suggesting 
that DDX11 has a role in averting genome instability and in promoting DNA repair of ICLs, 
but this function is genetically distinct and secondary in importance to one of canonical FA 
components. 
 
2-4-2 DDX11 facilitate DNA damage tolerance dependently on 9-1-1 check 
point clamp 
 
 Importantly, this study suggests that DDX11 also facilitates DNA damage tolerance of bulky 
lesions and replication through endogenous abasic sites, in a largely post-replicative manner 
and in collaboration with 9-1-1. Although previous studies reported accumulation of post-
replicative gaps in human and mouse cells in response to UV damage (Buhl et al., 1973; Buhl 
et al., 1972; Lehmann, 1972; Lehmann et al., 1977) or upon RAD51 depletion in Xenopus 
egg extracts (Hashimoto et al., 2010), little is known about how post-replicative repair is 
carried out in vertebrate cells. This study indicates that DDX11 collaborates with the 
checkpoint clamp 9-1-1 and its loader, RAD17, in the post-replicative HR repair of bulky 
lesions, and in facilitating gene conversion induced by abasic sites, but without affecting 
checkpoint activation. Based on the current findings, 9-1-1, in addition to its role as lesion 
sensor and activator of ATR, may participate together with DDX11 in the post-replicative 
bypass of replication lesions that are not preferential substrates for the canonical FA pathway 
or other fork stabilization mechanisms. A noncanonical role for 9-1-1 in the post-replicative 
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HR-mediated repair of replication lesions was observed in budding yeast (Karras et al., 2013), 
and that 9-1-1 repair defects can be overcome by overexpressing RAD51(Shinohara et al., 
2003). The data suggests a model in which the action of 9-1-1 favors the formation of the 
RAD51 filament on post-replicative gaps, while DDX11 promotes the unwinding of the 
stalled 3’ end. The intermediate formed by the joint actions of 9-1-1 and DDX11 may be 
efficiently matured into an HR intermediate, while in the absence of 9-1-1, the 3’ end exposed 





 The model in the presence of RAD17 (Left) and in the absence of RAD17 (Right).  
 
A joint role for DDX11 and 9-1-1 in the HR repair of replication lesions and abasic sites may 
explain why their individual depletion/knockout leads to very similar developmental defects 
in mouse, with the somitic mesoderm being especially sensitive to the genomic instability 
produced by their individual mutations (Cota and Garcia-Garcia, 2012; Weiss et al., 2000) 
and resembling the ones caused by mutations in BRCA2 and PALB2 (Rantakari et al., 2010; 
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Suzuki et al., 1997). These repair functions are likely critical in situations of fast proliferation, 
such as during early stages of development. I also found that DDX11 mitigates replication 
stress in FANCJ-defective cells and is critical for the repair of olaparib- and cisplatin-induced 
DNA damage in BRCA2 and FA-defective cells. Thus, another implication of our findings is 
that DDX11 is important for limiting replication stress in FA and BRCA mutated cells, and 
therefore it may be vital for the survival of these and other cancers, which often suffer from 
replication stress. Based on this study, I propose that the DNA repair pathway mediated by 
DDX11 has important functions related to replication of endogenous abasic sites and DNA 
damage tolerance of bulky lesions. This pathway is critical for human disease and may offer 







 Molecular Mechanism-Based High Throughput Screening to 
Identify the Chemicals Which Cause DNA Double-Strand Break 




3-1-1 Translational Science 
 
 As shown in Chapter 2, synthetic effects of concurrent loss of DDX11 and FA factor on 
genome maintenance and cell proliferation. Thus, the rapid proliferation of FA cancer cells 
might be largely supported by the complementary working DDX11. Similarly, genes related 
to DNA damage repair pathways are generally mutated in cancer cells and thus the survival 
of the cancer cells is maintained by alternative and complementary DNA repair pathways 
(e.g. BRCA1 and PARP). The inhibition of such complementary system results in cell growth 
defect or cell death.  To establish the novel cancer chemotherapy based on such genetic 
synthetic-relationship, I wish to establish a high throughput drug screening system based on 





3-1-2 Nuclear hormone receptor and cancer therapy 
 
Nuclear hormone receptors are ligand-activated transcription factors. When they bind to the 
ligand hormones, they move into the nucleus and regulate gene expression at their target 
sites. The target sites are called hormone response elements (HRE). The sequence of the 
site differs depending on the type of receptor. Each receptor has different HRE and 
regulates different cellular activities. Although nuclear hormone receptors are composed of 
several domains, two domains are differentially conserved in the various receptors. One is 







 Hormones are produced in the hormone system (i.e. endocrine system), which is the network 
of glands and organs. The hormone system includes the pituitary gland, pineal gland, thyroid 
gland, adrenal gland, pancreas, testis, and ovary. Once the hormone system produces 
hormones, our bloodstream carries the hormones around the body. Each hormone has a 
different role as each hormone receptor has a different role. They control growth and 
development, sexual function, reproduction, etc. Since some of the hormone receptors 
control cell proliferation, hormone receptor is one of the targets for cancer therapies 
(Rossouw et al., 2002). Hormone therapy uses chemicals to prevent the hormone receptor 
from binding hormones to lower amount of hormone-receptor complex. 
 
 There are environmental compounds that disrupt the endocrine system by acting like 
hormones (Ji et al., 2009). Those compounds are called environmental hormones. The most 
famous environmental hormone is a bis-phenol A. It is used in many plastic products and is 
known to have estrogenic activity and genotoxic activity (Lee et al., 2013).  However, how 
endocrine disruptor causes genotoxic effects had not been discovered. 
 
 
3-1-3 Female organ cancer and Estrogen / Progesterone receptor 
 
 Breast cancer is the most frequently diagnosed cancer in females. Breast cancer is classified 
into 4 groups depending on the expression of 3 receptors (Table 2). Estrogen receptor and 
progesterone receptor is activated by estrogen and progesterone, respectively. Human 
Epidermal growth factor Receptor 2 (HER2) has a strong ability to promote cell proliferation. 
HER2 is frequently overexpressed in breast cancer cells. The expression of HER2 is 
regulated by the estrogen receptor and the ligand for HER2 has not been identified yet. 
Because the proliferation of breast cancer tumor is mostly controlled by those receptors, 
inhibitors for those receptors are used to suppress cancer cell proliferation. However, breast 
cancer classified in group-4 does not rely on those receptors for the proliferation. The 







 Classifying the breast cancer group according to the expression of three receptors. 
 
 Because more than 70% of breast cancer express the estrogen receptor and it regulates HER2 
expression (Williamson and Lees-Miller, 2011), I focus on the estrogen receptor in this study. 
Once they are activated by estrogen, they translocate into the nucleus and bind to DNA to 
regulate transcription (Allred et al., 2004). There are two subtypes of ERs, (ER-α and ER-β). 
Both receptors promote transcription on their target genes. However, their roles in cells are 
different. While activation of ER-α promotes cell proliferation, activation of ER-β represses 
cell proliferation. Because ER-α is mainly expressed in breast, ER-α antagonist is used for 
preventing cancer cells from growing. Although ER-α is a common target for hormone 
therapy, there is a concern that the activation of ER can cause DNA damage (Stork et al., 
2016). The activation of the ER is known to accelerate cancer cells. But the genotoxicity has 
not been studied very well. 
 
 
3-1-4 Female organ cancer and BRCA1 
 
 BRCA1 is frequently mutated in breast and ovarian cancer (Nik-Zainal et al., 2019). Females 
who carry a mutation in BRCA1 genes have a lifetime risk for breast and ovarian cancer 75% 
and 65%, respectively (van der Kolk et al., 2010). BRCA1 is a multi-functional enzyme (e.g. 
DNA repair, checkpoint activation, apoptosis (Friedenson, 2005; Narod and Foulkes, 2004; 
Venkitaraman, 2002)). One of the well-known functions of BRCA1 is a key player in DNA 
Double-Strand Break (DSB) repair. DSB is a fatal DNA damage and can trigger genome 
instability (Khanna and Jackson, 2001). DSB is repaired mainly by two pathways. One is 
homologous recombination (HR) and the other is Non-Homologous End Joining (NHEJ). 
BRCA1 is involved in the HR pathway, which repairs DSB by using the sister chromosome 
Group1 Group2 Group3 Group4
Estrogen receptor 〇 〇 × ×
Progestorone receptor 〇 × × ×
HER2 receptor × 〇 〇 ×
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as a template (Farmer et al., 2005). Thus, BRCA1 deficiency results in less HR activity and 
the cells lacking BRCA1 show hypersensitivity to DSB-inducing agents, such as ionizing 
radiation. Although HR is activated in all kinds of cells mainly in the late-S/G2 phase (Takata 
et al., 1998), BRCA1 is strongly related to cancers in estrogen-regulated organs. 
 
The relationship between the mutation in the BRCA1 gene and these cancers had not been 
uncovered for a long time. According to the report from Dr. Takeda’s lab (Kyoto University, 
Japan), estrogen induces DSB depending on both ER-α activation and TOP2 (Sasanuma et 
al., 2018). TOP2 is the vital enzyme that resolves DNA supercoiling during transcription and 
replication. To resolve topological stress of DNA, TOP2 cuts and re-ligates DNA as well as 
Top1 (Pommier et al., 2016). A physiological concentration of estrogen activates ER-α and 
promotes ER-dependent transcription. During the transcription, TOP2 resolves DNA 
supercoiling by transiently generating DSB (Ju et al., 2006). TOP2 frequently fails to 
complete this process and remains on DNA, leading TOP2-cleavage complex (Top2cc). 
Remained unrepaired, Top2cc results in DSB. To remove this toxic Top2cc from DNA, 
MRE11 and TDP2 play an important role as a nuclease (Gómez-Herreros et al., 2013; Hoa 
et al., 2016). The amount of Top2cc increases in the absence of BRCA1. BRCA1 was found 
to be required to recruit MRE11 to the Top2cc damage site efficiently (Sasanuma et al., 2018) 
(Figure 44). This event occurs in the G0/G1 phase, suggesting BRCA1 has a role to repair 
Top2cc independent of HR. Moreover, BRCA1 has been believed to act only in S/G2 phase 
but not in the G1 phase. Cells with a mutation on BRCA1 fail to remove Top2cc, which is 
caused by ER activation, leading genome instability and promoting cancer development in 
female organs. This is how estrogen causes breast or ovarian cancer in females with 







 The scheme of the ER activation. 
 
 The loss of BRCA1 is embryonic lethal in the mouse model. This lethality is rescued by a 
disruption of 53BP1. 53BP1 protects DNA ends from resection to prevent unscheduled HR. 
BRCA1 removes 53BP1 from broken DNA ends. In the absence of BRCA1, 53BP1 remains 




3-1-5 High content / High throughput screening  
 
In this study, I aimed to identify environmental compounds that cause DNA damage 
through the activation of estrogen receptor as well as estrogen. To achieve this goal, I 
optimized high throughput / high content imaging screening system to measure DNA 
double-strand breaks. High content screening is an imaging-based assay (Li et al., 2018). It 
allows us to analyze the event in every single cell. On the other hand, we only can see the 
cellular events as a population in classical high throughput screenings. For this reason, high 
content screening gives us more about the cellular event compared to classical high 
throughput screening. Because DNA damaging activity of estrogen is not as strong as other 
DNA damaging agents (e.g. ionizing radiation), high content screening is needed.  
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 TK6 cells were cultured in RPMI 1640 medium (Sigma) supplemented with 10% heat-
inactivated horse serum (HS) (Sigma), 0.1 mM sodium pyruvate (Sigma), L-glutamine 
(Sigma), 50 U/mL penicillin, and 50 μg/mL streptomycin (Sigma). 
 
MCF7 
 MCF7 cells were cultured in DMEM medium supplemented with 10% heat-inactivated Fatal 
Bovine Serum (FBS), 0.01 mg/ml insulin, 50 U/mL penicillin, and 50 μg/mL streptomycin. 
 For assay, MCF7 cells were cultured in a phenol red-free DMEM medium supplemented 
with 1% charcoal stripped FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin 
 
CHO (WT) 
  CHO WT cells were cultured in F12K medium supplemented with 10% heat-inactivated 




  CHO WT cells were cultured in α-MEM medium supplemented with 10% heat-inactivated 
Fatal Bovine Serum (FBS), 50 U/mL penicillin, and 50 μg/mL streptomycin. 
 
Homogeneous Time Resolved Fluorescence: phospho-H2AX quantification assay 
(HTRF assay) 
I plated the cells at 2,000 cells/well in 5nl of culture medium into white solid bottom 1536-
well plates. I incubated the assay plate for 18 hours. The next day, I added 23nl of compounds 
and DMSO by pin tool, then incubated it for 3 hours. After the incubation, I added 1 μl of 
lysis mixture into each well and incubated it for 30min RT. Next, I added the antibody mixture 
solution and incubated it for 24 hours. Finally, I read the plate in Envision plate reader 
(excitation 320nm and emissions at 665nm and 620nm).    
Lysis mixture 
 a, Lysis buffer was diluted 4-fold with distilled water. 
 b, Blocking reagent was diluted 100-fold into prepared lysis buffer. 
Antibody mixture 
 Stock antibody solutions were diluted 20-fold with detection buffer. 
Solution A: Anti H2A.X-d2  
Solution B: Anti pH2A.X (S139)-K  




I plated MCF7 cells at 1,500 cells / well in 5 μl of the medium into a black wall/ clear bottom 
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1536 well plate. I incubated the assay plate for 18 hours. The next day, I added 23 nl of 
compounds and DMSO by pin tool, then incubated it for 3 hours. Next, I added 5μl of 8% 
paraformaldehyde (final concentration: 4%) and incubate for 20 minutes. After a wash with 
PBS, I added a blocking/ permeabilization buffer and incubated for 30 min. Then, I treated 
the cells with the primary antibody for 45minutes at RT, followed by the incubation with the 
secondary antibody for 30 minutes at RT. I read the plates in the operetta plate reader. 
Data analysis 
I counted the foci per cell using operetta. Analysis of compound concentration–response data 
was performed as previously described. Briefly, raw plate reads for each titration point were 
first normalized relative to the positive control compound (sunitinib) and DMSO only wells 
(0%) as follows:  
%Activity = [(Vcompound -VDMSO) / (Vpos -VDMSO)] x 100  
where Vcompound denotes the compound well values, Vpos denotes the median value of the 
positive control wells, and VDMSO denotes the median values of the DMSO-only wells. The 
data set was then corrected using the DMSO-only compound plates at the beginning and end 
of the compound plate stack by applying an in-house pattern correction algorithm. The half 
maximum effective values (IC50) for each compound and maximum response (efficacy) 
values were obtained by fitting the concentration–response curves of each compound to a 
four-parameter Hill equation. Compounds were designated as class 1–4 according to the type 
of concentration–response curve observed (Figure 45). In the present study, antagonists were 
defined as compounds that inhibited angiogenesis activity. Compounds with class 1.1, 1.2, 
2.1, 2.2, 3 curves were considered active, compounds with class 4 curves were considered 
inactive, and compounds with all other curve classes were defined as inconclusive. Data were 
analyzed and depicted using OriginPro 2015 (OriginLab Corp., Northampton, MA) and 





CV value, Signal/ Background (S/B) ratio, and Z’- factor was calculated as below. 
CV value: 
The coefficient of variation (CV) is a measure of relative variability. It is the ratio of the 
standard deviation to the mean (average) 
Coefficient of Variation (CV) = (Standard Deviation / Mean) * 100. 
 
Signal/ Background (S/B) ratio: 
S/B ratio is the ratio of the signal to the background signal. 
 
Z’ factor: 
The Z-factor is a measure of statistical effect size.  
Z’- factor = 1 – 3(σp+ σn)/|μp-μn| 








3-3-1 Development of the assay system to identify DNA double strand 
inducers 
Molecular biological studies allow us to develop molecular targeting chemotherapy. We need 
high throughput assay system to identify the compounds with a certain activity. I aimed to 
utilize antibody reaction in 1536 plate format, because antibody reaction can focus specific 
protein. From great number of antibodies, once I optimize the assay, it can be very versatile. 
I picked the DNA double strand break (DSB) as the model target for the assay development. 
I chose phospho-H2AX as a biomarker for DSB.  
 
 First, I tested if the Homogeneous Time Resolved Fluorescence: phospho-H2AX 
quantification assay (HTRF assay) is available for MCF7 or TK6 cells. Phosphor-H2AX is 
used as a biomarker for DSB. H2AX HTRF assay is a fluorescence resonance energy transfer 
(FRET)-based technology. FRET is a distance-dependent physical process, by which energy 
is transferred nonradiatively from an excited molecular fluorophore (the donor) to another 
fluorophore (the acceptor) by means of intermolecular long-range dipole–dipole coupling 
(Sekar and Periasamy, 2003). In HTRF assay, cells were lysed after the chemical treatment, 
followed by incubation with HTRF antibodies. One of the antibodies is conjugated with the 
donor and recognizes the phosphorylated H2AX. The other antibody is conjugated with the 
acceptor and recognizes H2AX independent of its phosphorylation state. The performance of 
HTRF assay depends on cell types. I treated BRCA1-/-/53BP1-/- deficient MCF7 and TK6 with 
H2O2, Camptothecin, Actinomycin, and Bleomycin. None of them showed phospho-H2AX 
induction (Figure 46). 
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Figure 45 
The result of HTRF assay. Y axis indicates the fold change compared to DMSO treated cells. 
X axis indicates the dose. 
 
 
To find a better cell-based high-throughput assay system to quickly identify compounds that 
induce DNA double-strand break, I optimized and validated an immunostaining assay using 
a quantitative high-throughput and high-content imaging method. To validate this assay, 
MCF7 cells were plated in a 1536-well plate. Bleomycin, a known DNA damage inducer, 
caused phosphorylation of H2AX in a concentration-dependent manner in a 1536-well plate 
using the number of nuclei count and the number of spot count measurements (Figure 46). 
In the screening, “the number of foci per cell” was used for the quantitative image analysis 
of phospho-H2AX induction. The immunostaining assay was validated in 1536-well formats 
using Bleomycin with average signal-to-background (S/B) ratio, coefficient of variation (CV) 









Figure 46  
The dose response curves (upper panel) and the representative image for each dose point 





















3-3-2 Identification of phospho-H2AX inducer using high content imaging 
analysis 
 
 I examined DSB inducers in a tiered testing approach (Figure 45). I have selected 907 
compounds that potentially induce DSB, based on previous screening using the Tox21 10K 
chemical library (Huang et al., 2016). I used bleomycin as a positive control. These 








The average CV value, S/B ratio, and Z′ factor from the primary screen of 21 assay plates 
were 14.85 ± 5.77%, 5.53 ± 2.02, and 0.32 ± 0.14, respectively. The compounds in the curve 
classes of 1.1, 1.2, 2.1, 2.2 were considered active and potential phospho-H2AX inducer. The 
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number of foci per cell by positive control (bleomycin) is defined as 100% activity of the 
compounds. The number of foci per cell by negative control (DMSO) is defined as 0% 
activity of the compounds. The activity was calculated for each compound in each dose point. 
The half-maximal activity concentration (AC50) is the concentration in which the compound 
shows 50% activity compared to the control compounds. Efficacy is the maximum activity 
of each compound. From the primary screening, 128 potential inducers were identified and 
selected for the follow-up study (Table 3).  
 
Sample Name AC50(mM) Efficacy(%) 
Curve 
Class 
Oxyphenisatin acetate 0.1 ± 0.0 59.5 ± 9.1 1.1 
Carminomycin 0.2 ± 0.1 110.8 ± 19.2 2.1 
8-Quinolinol Salicylic acid (1:1) 6.5 ± 2.4 71.3 ± 5.0 2.1 
NSC-12155 (surfen) 24.5 ± 3.1 112.3 ± 49.8 1.1 
Topotecan hydrochloride 14.9 ± 1.7 93.4 ± 4.0 1.1 
Mitoxantrone 0.7 ± 0.1 101.7 ± 10.8 1.1 
Raloxifene hydrochloride 22.1 ± 10.2 80.2 ± 17.1 1.1 
Sanguinarine 10.8 ± 5.1 77.2 ± 20.8 1.1 
Disulfiram 0.6 ± 0.3 85.3 ± 7.0 1.1 
Bisacodyl 0.6 ± 0.1 47.7 ± 6.6 1.1 
Curcumin 34.8 ± 18.6 58.9 ± 16.8 1.1 
Resveratrol 2.1 ± 0.8 120.4 ± 25.5 1.1 
Podofilox 1.1 ± 0.1 121.5 ± 6.8 1.1 
Daunorubicin 0.5 ± 0.0 118.6 ± 23.8 1.1 
Actinomycin D 0.3 ± 0.0 75.6 ± 7.7 1.1 
N,N-Diethyl-p-phenylenediamine 4.6 ± 4.1 46.8 ± 15.9 1.1 
4-(2-Methylbutan-2-yl)phenol 1.7 ± 0.9 50.7 ± 0.5 1.1 
4-Chloro-1,2-diaminobenzene 27.7 ± 19.2 60.1 ± 9.6 1.1 
2,3,4-Trichlorophenol 5.3 ± 0.6 122.4 ± 15.9 2.1 
Amsacrine 11.9 ± 6.7 125.2 ± 25.0 1.1 
Semaxanib 6.6 ± 5.6 38.6 ± 9.5 1.1 
Chloroxine 3.6 ± 0.6 68.0 ± 26.7 1.1 
Gramicidin 1.5 ± 1.1 63.5 ± 33.5 1.1 
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Ethacridine lactate 15.2 ± 12.5 92.6 ± 28.3 1.1 
Tetramethylthiuram monosulfide 1.4 ± 0.3 83.9 ± 8.5 1.1 
Testosterone decanoate 3.2 ± 3.0 116.8 ± 30.3 2.1 
Nitroxoline 3.0 ± 3.1 63.2 ± 14.2 1.1 
1,4-NAPHTHOQUINONE 9.5 ± 2.0 57.4 ± 20.9 1.1 
Tiliquinol 1.9 ± 0.7 74.8 ± 9.5 2.1 
Rubitecan 8.3 ± 3.0 53.2 ± 7.2 1.1 
Pirarubicin 10.2 ± 7.4 96.1 ± 20.0 1.1 
Dithiazanine iodide 18.4 ± 11.4 46.8 ± 15.1 1.1 
Carboquone 13.9 ± 2.5 74.6 ± 8.0 1.1 
Dicyclopentamethylenethiuram 
disulfide 
0.7 ± 0.3 100.3 ± 21.0 1.1 
Peplomycin sulfate 17.3 ± 1.2 39.3 ± 5.6 1.1 
Eprinomectin B1a 21.5 ± 8.4 69.4 ± 14.2 2.1 
Lestaurtinib 18.0 ± 5.9 45.5 ± 9.2 2.1 
Gimatecan 2.1 ± 1.8 96.0 ± 25.0 2.1 
Menadiol 8.7 ± 0.6 88.6 ± 22.2 1.1 
2,3-Diaminotoluene 35.4 ± 17.7 64.2 ± 11.7 1.2 
Sodium (2-pyridylthio)-N-oxide 5.5 ± 3.4 83.7 ± 6.8 2.1 
2,4-Bis(1-methyl-1-
phenylethyl)phenol 
28.9 ± 8.5 64.8 ± 21.0 2.1 
Sodium dimethyldithiocarbamate 8.7 ± 3.3 88.1 ± 8.2 1.1 
Ziram 1.4 ± 0.8 89.1 ± 18.9 2.1 
Captafol 13.8 ± 3.2 86.1 ± 2.2 2.1 
Dazomet 6.4 ± 1.1 87.5 ± 4.2 1.1 
4-Dodecylphenol 27.7 ± 14.8 45.8 ± 17.2 2.1 
Methylene bis(thiocyanate) 41.1 ± 2.7 55.6 ± 17.9 2.1 
2-
(Thiocyanomethylthio)benzothiazole 
46.6 ± 6.4 103.9 ± 56.5 1.1 
3,4,5,6-Tetrachloro-2-
pyridinecarbonitrile 
37.5 ± 9.4 79.7 ± 10.2 1.1 
3,3'-Diaminobenzidine 39.8 ± 2.7 62.6 ± 28.2 2.1 
Dipentaerythritol pentaacrylate 20.5 ± 1.3 84.2 ± 10.3 2.1 
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Dithianon 6.6 ± 1.1 116.1 ± 15.9 1.1 
3-Hydroxy-2-naphthoic o-anisidide 19.7 ± 20.1 99.4 ± 63.8 2.1 
Potassium dicyanoaurate 3.9 ± 1.3 82.6 ± 7.5 2.1 
Phenylarsine oxide 1.4 ± 0.3 85.8 ± 7.4 1.1 
2,3,4,5-Tetrachloro-6-
(trichloromethyl)pyridine 
6.5 ± 4.9 82.9 ± 17.5 2.1 
1,1,2-Trimethyl-1H-benzo[e]indole 6.1 ± 0.7 64.6 ± 9.2 1.1 
6-Nitrobenzimidazole 5.9 ± 2.8 93.7 ± 12.3 2.1 
Rhodamine 6G 12.7 ± 4.8 70.1 ± 16.0 1.1 
2,4-Diaminoanisole sulfate hydrate 30.5 ± 3.9 94.6 ± 14.2 1.1 
2-Aminoanthracene 6.5 ± 2.7 51.3 ± 9.5 2.1 
Oxyphenisatin 0.3 ± 0.0 64.7 ± 3.1 2.1 
Nemorubicin 10.1 ± 0.7 84.6 ± 16.2 2.1 
Teniposide 5.7 ± 4.4 128.9 ± 41.6 2.1 
Etoposide 18.0 ± 1.2 105.3 ± 3.6 2.1 
THIRAM 0.9 ± 0.1 77.6 ± 1.1 2.1 
Idarubicin hydrochloride 0.1 ± 0.1 83.9 ± 6.0 1.1 
Cloxyquin 5.8 ± 5.0 73.5 ± 34.2 1.1 
Estradiol dipropionate 21.1 ± 3.4 81.9 ± 4.6 1.1 
Geliomycin 18.8 ± 3.0 53.1 ± 2.6 1.1 
1,4-dihydroxy-2-naphthoic acid 24.7 ± 7.9 125.4 ± 35.4 1.1 
Dihydrotachysterol 24.9 ± 2.0 39.8 ± 12.2 2.1 
Bismuth subgallate 12.7 ± 3.1 122.1 ± 9.0 1.1 
Nitrovin 7.1 ± 1.7 55.7 ± 21.1 1.1 
Estramustine phosphate 13.1 ± 11.1 75.0 ± 36.0 2.1 
Nitromersol 22.5 ± 5.4 52.4 ± 22.0 1.1 
Methyl 3-amino-5,6-
dichloropyrazine-2-carboxylate 
26.5 ± 4.3 45.7 ± 18.8 1.1 
p,p'-DDD 48.4 ± 7.8 53.0 ± 14.4 1.1 
PD 0343701 13.6 ± 0.0 102.8 ± 19.5 2.1 
Barban 42.9 ± 0.0 59.9 ± 32.1 1.1 
3,4,4'-Triaminodiphenyl ether 40.5 ± 3.3 74.4 ± 19.0 2.1 




14.4 ± 1.2 71.3 ± 2.1 1.1 
Dichlone 5.3 ± 2.1 71.6 ± 2.8 1.1 
Pentaerythritol triacrylate 48.1 ± 0.0 100.5 ± 14.1 2.1 
Manganese(II) acetate 36.1 ± 17.0 82.1 ± 52.7 1.1 
2,2'-Methylenebis(ethyl-6-tert-
butylphenol) 
15.3 ± 2.5 33.1 ± 0.2 1.1 
Proflavin hydrochloride 1.0 ± 1.3 67.6 ± 35.3 1.1 
1-Decyl-3-methylimidazolium 
trifluoromethanesulfonate 
37.1 ± 3.0 43.0 ± 4.1 2.1 
 
Table 3 




12 compounds induce phosphorylation on H2AX depending on Estrogen 
receptor 
 
I re-cherry picked 128 compounds. Because MCF7 is a breast cancer cell line with an 
expression of estrogen receptor, I focused on Estrogen receptor-dependent DNA double 
strand break. To test the induction of phospho-H2AX depends on the estrogen receptor, I 
exposed the cells to the compounds with or without tamoxifen, an inhibitor for estrogen 
receptor. For 12 out of 128 compounds, the amount of phospho-H2AX was reduced by 
tamoxifen (Figure 48), suggesting their DNA damaging activities depend on estrogen 







The dose response curve for the indicated compounds. Cells are exposed to the compounds 
with Tamoxifen (Orange line) or without Tamoxifen (Blue line). Y axis indicates the activity 





 In this study, I optimized the high throughput/ high content screening assay format to detect 
DNA double strand breaks in 1536 well plate format. In the previous cell-based screening 
system, the data was obtained from the population. Since high content screening applies 
imaging based data analysis, it can observe the event in each single cell. I identified 128 DSB 
inducers. I identified 14 compounds, which induce DNA double strand breaks via the 
activation of the estrogen receptor. 
 
The new assay I optimized utilizes antibody reaction which allow us to identify the 
compounds that have specific activity in the cells. For example, this assay can be used to 
identify the disrupter of certain proteins. Current drug discovery focuses on molecular 
mechanism. Although many researches about molecular mechanism allow us to plan the 
strategy for the drug discovery, there was no efficient assay system to utilizes the molecular 
mechanism data. This assay helps us to efficiently identify molecular-targeting drug for 




 In this study, I investigated the molecular mechanism related to ALC1 and DDX11 to 
maintain genome information. The information helps us to develop molecular targeting 
chemotherapy. In addition, I have created a high throughput drug screening system, based on 
the DNA repair mechanism in cells, to potentially create a novel cancer chemotherapy 
through synthetic lethality using specific inhibitors for DNA repair enzymes. 
 In chapter 1, I focused on the role of ALC1 in the repair of base damage and CPT-induced 
DNA damage. Base damage is the most common DNA damage. Although BER is well 
studied repair pathway, there still are many things unknown. PARP, XRCC1 and Polβ plays 
main role in BER (Sharbeen et al., 2015). Recently, ALC1 was found to have the PARP 
interacting domain in the structure (Ahel et al, 2010). However, the role played by ALC1 and 
interaction with PARP is largely unknown. I found the epistatic relationship between ALC1 
and PARP. Moreover, ALC1 works as a chromatin remodeler independently of XRCC1 and 
Polβ. I also found ALC1 works with PARP in the repair of Camptothecin (CPT)-induced 
DNA damage. CPT is used for a cancer chemotherapy. CPT inhibits re-sealing step of DNA 
topoisomerase-I during DNA replication, and thereby induces SSBs associated with TopI-cc 
their 3’ end. This data suggests that ALC1 works on DNA replication. BER pathway is 
independent of DNA replication. The data suggests ALC1’s possible role on DNA replication. 
The over expression of ALC1 reduces 5-year survival after diagnosis of liver cancer 
(https://www.proteinatlas.org/). This may be because over expression of ALC1 induces 
unscheduled chromatin remodeling, leading to toxic translocation.  
 
 In chapter 2, I investigated the role of DDX11. DDX11 is mutated in Warsaw breakage 
syndrome (WABS). The cells from WABS patient shows similar phenotype to the cells from 
Fanconi Anemia patients. The cells are sensitive to DNA inter-strand crosslink (ICL). I found 
that DDX11 works as a backup pathway for Fanconi anemia pathway in the repair of ICL. I 
also found DDX11 works in the DNA replication. In the immunoglobulin diversification 
assay, DDX11 mutant shows less gene conversion rate and point mutation rate, suggesting 
DDX11 have a role in both homologous recombination-mediated template switch and 
translesion DNA synthesis. While DDX11 is known to work in homologous recombination 
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as a helicase, the role played by DDX11 in TLS has been unappreciated and this study newly 
identified this function. 
Molecular biological studies, as I did in chapter 1 and 2, helps us to establish new approach 
for cancer chemotherapy. Inhibition of two proteins in a certain combination, as DDX11 and 
Fanconi anemia proteins, prevents cell proliferation. This effect is referred to as a synergistic 
effect. The most successful molecular targeting chemotherapy is olaparib. Olaparib inhibits 
PARP. PARP is in the synergistic relationship with BRCA1. Mutation on BRCA1 increases 
the risk for breast cancer, which is why olaparib is widely used for breast cancer 
chemotherapy. However, not many molecular targeting drugs are used. One of the reasons is 
that the relationship between genes are largely unknown. Another reason is there are no 
appropriate methods to screen the drug. 
 In chapter 3, I aimed to establish the screening system focusing on molecular function. In 
the lab environment, there are many methods to test protein accumulation, but they are too 
low throughput to carry out drug screening. I optimized antibody-based screening system to 
detect protein accumulation in high throughput screening format. In this study, I used γH2AX 
(phosphorylated H2AX), which is used as a biomarker for DNA double strand break, as a 
model for assay development.  
In the screening, I used MCF7 breast cancer cell line for the assay optimization. I screened 
907 compounds from Tox21-10K chemical library at the National Center for Advancing 
Translational Science/ National Institutes of Health (NCATS/NIH). These compounds were 
directly or indirectly related to DSB from previous screenings done at NCATS/NIH (Hsieh 
et al., 2019). The average CV value, S/B ratio, and Z’ factor from the primary screen of 21 
assay plates were 14.85%, 5.53, and 0.32, respectively. The compounds, with efficacy of 
>3SD from the negative control (DMSO), were considered active and potential γH2AX 
inducers. A total of 128 potential inducers were identified from the primary screening. Since 
MCF7 express estrogen receptor, I sought to identify compounds, which cause DNA double 
strand breaks through estrogen receptor activation. I identified 12 compounds with the 
criteria. The result suggests that it is easy to modify the condition depending on the purpose. 
In this study, I achieved three things. First, that ALC1 works as a chromatin remodeler 
together with PARP in BER. ALC1 also works in the repair of Camptothecin-induced DNA 
damage. Second, that DDX11 works as a backup of Fanconi anemia pathway in the repair of 
ICLs. Furthermore, I identified DDX11’s role in DNA replication and the relationship 
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between DDX11 and other proteins which work to tolerate DNA replication stress. Finally, I 
optimized a high throughput imaging analysis to measure the amount of DNA damage in 
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